<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7356537\results\search\disease\results.xml">
  <result pre="MedjcmJournal of Clinical Medicine2077-0383MDPI pmcid: 7356537 doi: 10.3390/jcm9061683jcm-09-01683 : Review" exact="Acute Coronary Syndromes" post="and Covid-19: Exploring the Uncertainties https://orcid.org/0000-0003-0720-3380SchiavoneMarco12â€ GobbiCecilia2â€ Biondi-ZoccaiGiuseppe34Dâ€™AscenzoFabrizio5PalazzuoliAlberto6GasperettiAlessio1https://orcid.org/0000-0002-3774-0104MitacchioneGianfranco1VieccaMaurizio1GalliMassimo78FedeleFrancesco9ManconeMassimo9*https://orcid.org/0000-0001-8895-8915ForleoGiovanni Battista12[1],"/>
  <result pre="of Clinical Medicine2077-0383MDPI pmcid: 7356537 doi: 10.3390/jcm9061683jcm-09-01683 : Review Acute" exact="Coronary Syndromes" post="and Covid-19: Exploring the Uncertainties https://orcid.org/0000-0003-0720-3380SchiavoneMarco12â€ GobbiCecilia2â€ Biondi-ZoccaiGiuseppe34Dâ€™AscenzoFabrizio5PalazzuoliAlberto6GasperettiAlessio1https://orcid.org/0000-0002-3774-0104MitacchioneGianfranco1VieccaMaurizio1GalliMassimo78FedeleFrancesco9ManconeMassimo9*https://orcid.org/0000-0001-8895-8915ForleoGiovanni Battista12[1],"/>
  <result pre="Clinical Medicine2077-0383MDPI pmcid: 7356537 doi: 10.3390/jcm9061683jcm-09-01683 : Review Acute Coronary" exact="Syndromes" post="and Covid-19: Exploring the Uncertainties https://orcid.org/0000-0003-0720-3380SchiavoneMarco12â€ GobbiCecilia2â€ Biondi-ZoccaiGiuseppe34Dâ€™AscenzoFabrizio5PalazzuoliAlberto6GasperettiAlessio1https://orcid.org/0000-0002-3774-0104MitacchioneGianfranco1VieccaMaurizio1GalliMassimo78FedeleFrancesco9ManconeMassimo9*https://orcid.org/0000-0001-8895-8915ForleoGiovanni Battista12[1],"/>
  <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Since an association between" exact="myocardial infarction" post="(MI) and respiratory infections has been described for influenza"/>
  <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract Since an association between myocardial infarction (MI) and" exact="respiratory" post="infections has been described for influenza viruses and other"/>
  <result pre="Abstract Since an association between myocardial infarction (MI) and respiratory" exact="infections" post="has been described for influenza viruses and other respiratory"/>
  <result pre="respiratory infections has been described for influenza viruses and other" exact="respiratory" post="viral agents, understanding possible physiopathological links between severe acute"/>
  <result pre="infections has been described for influenza viruses and other respiratory" exact="viral" post="agents, understanding possible physiopathological links between severe acute respiratory"/>
  <result pre="other respiratory viral agents, understanding possible physiopathological links between severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes"/>
  <result pre="respiratory viral agents, understanding possible physiopathological links between severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS)"/>
  <result pre="viral agents, understanding possible physiopathological links between severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is"/>
  <result pre="links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and" exact="acute" post="coronary syndromes (ACS) is of the greatest importance. The"/>
  <result pre="an underestimation of ACS cases all over the world, but" exact="acute" post="MI still represents a major cause of morbidity and"/>
  <result pre="mortality worldwide and should not be overshadowed during the coronavirus" exact="disease" post="(Covid-19) pandemic. No common consensus regarding the most adequate"/>
  <result pre="measures employed to treat ACS in China during the first" exact="disease" post="outbreak and what currently represents clinical practice across Europe"/>
  <result pre="This review aims to discuss the pathophysiological links between MI," exact="respiratory" post="infections, and Covid-19; epidemiological data related to ACS at"/>
  <result pre="management of ACS patients with confirmed or suspected SARS-CoV-2 infection." exact="acute" post="coronary syndromes myocardial infarction STEMI Covid-19 infectious disease respiratory"/>
  <result pre="patients with confirmed or suspected SARS-CoV-2 infection. acute coronary syndromes" exact="myocardial infarction" post="STEMI Covid-19 infectious disease respiratory infections pathophysiology percutaneous coronary"/>
  <result pre="suspected SARS-CoV-2 infection. acute coronary syndromes myocardial infarction STEMI Covid-19" exact="infectious disease" post="respiratory infections pathophysiology percutaneous coronary intervention thrombolysis drug treatment"/>
  <result pre="SARS-CoV-2 infection. acute coronary syndromes myocardial infarction STEMI Covid-19 infectious" exact="disease" post="respiratory infections pathophysiology percutaneous coronary intervention thrombolysis drug treatment"/>
  <result pre="infection. acute coronary syndromes myocardial infarction STEMI Covid-19 infectious disease" exact="respiratory" post="infections pathophysiology percutaneous coronary intervention thrombolysis drug treatment 1."/>
  <result pre="acute coronary syndromes myocardial infarction STEMI Covid-19 infectious disease respiratory" exact="infections" post="pathophysiology percutaneous coronary intervention thrombolysis drug treatment 1. Introduction"/>
  <result pre="drug treatment 1. Introduction In December 2019, an outbreak of" exact="pneumonia" post="caused by a novel coronavirus occurred in Wuhan, Hubei"/>
  <result pre="(US), and the rest of the world [1,2,3], reaching a" exact="total" post="number of 3,435,894 confirmed cases worldwide as of 5"/>
  <result pre="as a pandemic. Patients exposed to this virus, named severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), frequently present with fever,"/>
  <result pre="a pandemic. Patients exposed to this virus, named severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), frequently present with fever, cough,"/>
  <result pre="pandemic. Patients exposed to this virus, named severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), frequently present with fever, cough, and"/>
  <result pre="to 14 days after exposure, and then usually develop coronavirus" exact="disease" post="(Covid-19)-related pneumonia [5]. Although respiratory symptoms prevail among all"/>
  <result pre="days after exposure, and then usually develop coronavirus disease (Covid-19)-related" exact="pneumonia" post="[5]. Although respiratory symptoms prevail among all clinical manifestations"/>
  <result pre="and then usually develop coronavirus disease (Covid-19)-related pneumonia [5]. Although" exact="respiratory" post="symptoms prevail among all clinical manifestations of Covid-19, preliminary"/>
  <result pre="Covid-19, preliminary studies showed that some patients may develop severe" exact="cardiovascular" post="(CV) damage, while other patients with underlying CV diseases"/>
  <result pre="of an overwhelmed healthcare system, screening and elective treatments of" exact="coronary artery disease" post="(CAD) have been underestimated, meaning dealing with acute coronary"/>
  <result pre="an overwhelmed healthcare system, screening and elective treatments of coronary" exact="artery disease" post="(CAD) have been underestimated, meaning dealing with acute coronary"/>
  <result pre="overwhelmed healthcare system, screening and elective treatments of coronary artery" exact="disease" post="(CAD) have been underestimated, meaning dealing with acute coronary"/>
  <result pre="coronary artery disease (CAD) have been underestimated, meaning dealing with" exact="acute" post="coronary syndromes (ACS) has become more complicated and apparently"/>
  <result pre="than 1 million hospital admissions in the US annually, while" exact="ischemic heart disease" post="accounts for almost 1.8 million annual deaths, or 20%"/>
  <result pre="1 million hospital admissions in the US annually, while ischemic" exact="heart" post="disease accounts for almost 1.8 million annual deaths, or"/>
  <result pre="million hospital admissions in the US annually, while ischemic heart" exact="disease" post="accounts for almost 1.8 million annual deaths, or 20%"/>
  <result pre="evaluating the best strategy to balance optimal ACS management and" exact="infectious" post="risks related to Covid-19 outbreak. 2. Acute Coronary Syndromes"/>
  <result pre="ACS management and infectious risks related to Covid-19 outbreak. 2." exact="Acute Coronary Syndromes" post="and COVID-19 2.1. Pathophysiology Acute coronary syndromes (ACS) reflect"/>
  <result pre="management and infectious risks related to Covid-19 outbreak. 2. Acute" exact="Coronary Syndromes" post="and COVID-19 2.1. Pathophysiology Acute coronary syndromes (ACS) reflect"/>
  <result pre="and infectious risks related to Covid-19 outbreak. 2. Acute Coronary" exact="Syndromes" post="and COVID-19 2.1. Pathophysiology Acute coronary syndromes (ACS) reflect"/>
  <result pre="Covid-19 outbreak. 2. Acute Coronary Syndromes and COVID-19 2.1. Pathophysiology" exact="Acute" post="coronary syndromes (ACS) reflect a spectrum of pathological conditions"/>
  <result pre="syndromes (ACS) reflect a spectrum of pathological conditions compatible with" exact="acute" post="myocardial ischemia or infarction that are usually due to"/>
  <result pre="(ACS) reflect a spectrum of pathological conditions compatible with acute" exact="myocardial ischemia" post="or infarction that are usually due to an abrupt"/>
  <result pre="reflect a spectrum of pathological conditions compatible with acute myocardial" exact="ischemia" post="or infarction that are usually due to an abrupt"/>
  <result pre="flow [11]. The clinical spectrum of ACS may range from" exact="myocardial infarction" post="with ST-segment elevation (STEMI), which generally reflects an acute"/>
  <result pre="myocardial infarction with ST-segment elevation (STEMI), which generally reflects an" exact="acute" post="total coronary occlusion, to myocardial infarction without ST-segment elevation"/>
  <result pre="infarction with ST-segment elevation (STEMI), which generally reflects an acute" exact="total" post="coronary occlusion, to myocardial infarction without ST-segment elevation (NSTEMI)"/>
  <result pre="with ST-segment elevation (STEMI), which generally reflects an acute total" exact="coronary occlusion," post="to myocardial infarction without ST-segment elevation (NSTEMI) or unstable"/>
  <result pre="(STEMI), which generally reflects an acute total coronary occlusion, to" exact="myocardial infarction" post="without ST-segment elevation (NSTEMI) or unstable angina (UA), with"/>
  <result pre="coronary occlusion, to myocardial infarction without ST-segment elevation (NSTEMI) or" exact="unstable angina" post="(UA), with or without myocardial injury, respectively [12]. The"/>
  <result pre="myocardial injury, respectively [12]. The current fourth universal definition defines" exact="myocardial infarction" post="(MI) as the presence of acute myocardial injury, detected"/>
  <result pre="universal definition defines myocardial infarction (MI) as the presence of" exact="acute" post="myocardial injury, detected by an elevated cardiac troponin (cTn)"/>
  <result pre="cardiac troponin (cTn) value above the 99th percentile of the" exact="upper" post="reference limit (URL), in the setting of evidence of"/>
  <result pre="upper reference limit (URL), in the setting of evidence of" exact="acute" post="myocardial ischemia related to symptoms, electrocardiogram (ECG), imaging changes,"/>
  <result pre="reference limit (URL), in the setting of evidence of acute" exact="myocardial ischemia" post="related to symptoms, electrocardiogram (ECG), imaging changes, or angiographic"/>
  <result pre="limit (URL), in the setting of evidence of acute myocardial" exact="ischemia" post="related to symptoms, electrocardiogram (ECG), imaging changes, or angiographic"/>
  <result pre="to the mismatch between oxygen supply and demand, such as" exact="respiratory" post="failure (predominantly hypoxaemia) and infectious disease (particularly sepsis), may"/>
  <result pre="supply and demand, such as respiratory failure (predominantly hypoxaemia) and" exact="infectious disease" post="(particularly sepsis), may induce or lead to myocardial injury"/>
  <result pre="and demand, such as respiratory failure (predominantly hypoxaemia) and infectious" exact="disease" post="(particularly sepsis), may induce or lead to myocardial injury"/>
  <result pre="sepsis), may induce or lead to myocardial injury or to" exact="type 2" post="MI [13,15,16]. Mechanisms related to myocardial injury are summarized"/>
  <result pre="to myocardial injury are summarized in Table 1. Identification of" exact="type 2" post="MI can be challenging due to more frequent atypical"/>
  <result pre="type 2 MI can be challenging due to more frequent" exact="atypical" post="clinical presentations (such as with dyspnoea), higher prevalence of"/>
  <result pre="as with dyspnoea), higher prevalence of comorbidities that may mask" exact="ischemia" post="[17], and lower frequency of ischemic electrocardiographic findings (Q"/>
  <result pre="higher prevalence of comorbidities that may mask ischemia [17], and" exact="lower" post="frequency of ischemic electrocardiographic findings (Q waves or new"/>
  <result pre="[18,19,20,21]. Nowadays, it is well accepted that sepsis and other" exact="infections" post="are associated with CV events, especially ACS [22,23]. In"/>
  <result pre="In particular, the risk of MI in the context of" exact="respiratory" post="infectious disease reaches a peak at the onset of"/>
  <result pre="particular, the risk of MI in the context of respiratory" exact="infectious disease" post="reaches a peak at the onset of infections and"/>
  <result pre="the risk of MI in the context of respiratory infectious" exact="disease" post="reaches a peak at the onset of infections and"/>
  <result pre="respiratory infectious disease reaches a peak at the onset of" exact="infections" post="and is proportional to the severity of illness [22]."/>
  <result pre="infections and is proportional to the severity of illness [22]." exact="Acute" post="respiratory failure with consequent severe hypoxaemia contributes to reduce"/>
  <result pre="and is proportional to the severity of illness [22]. Acute" exact="respiratory" post="failure with consequent severe hypoxaemia contributes to reduce oxygen"/>
  <result pre="supply and determines activation of the sympathetic system, which increases" exact="heart" post="rate, cardiac output, and contractility, factors that can increase"/>
  <result pre="as post-mortem studies have suggested, where a prevalence of undiagnosed" exact="acute" post="myocardial infarction (AMI) ranging from 5% to 25% in"/>
  <result pre="post-mortem studies have suggested, where a prevalence of undiagnosed acute" exact="myocardial infarction" post="(AMI) ranging from 5% to 25% in patients who"/>
  <result pre="ranging from 5% to 25% in patients who died from" exact="acute" post="respiratory failure was observed [27,28]. Another possible mechanism implicated"/>
  <result pre="from 5% to 25% in patients who died from acute" exact="respiratory" post="failure was observed [27,28]. Another possible mechanism implicated in"/>
  <result pre="observed [27,28]. Another possible mechanism implicated in the association between" exact="respiratory" post="tract infections and ACS is the pro-inflammatory state. Since"/>
  <result pre="Another possible mechanism implicated in the association between respiratory tract" exact="infections" post="and ACS is the pro-inflammatory state. Since this association"/>
  <result pre="inflammatory cells that proliferate and secrete cytokines that stimulate smooth" exact="muscle" post="cells to form a fibrous cap [29]. An inflammatory"/>
  <result pre="form a fibrous cap [29]. An inflammatory state at any" exact="other site" post="generates circulating cytokines, such as interleukins 1, 6, and"/>
  <result pre="circulating cytokines, such as interleukins 1, 6, and 8 and" exact="tumor" post="necrosis factor Î±, which can activate inflammatory cells in"/>
  <result pre="shown that inflammatory activity in atheromatous plaques increases after an" exact="infectious" post="stimulus. When activated, intraplaque inflammatory cells, especially macrophages and"/>
  <result pre="factor, and platelet-adhesive matrix molecules) are exposed, leading to the" exact="acute" post="formation of a thrombus, which is the typical mechanism"/>
  <result pre="of a thrombus, which is the typical mechanism related to" exact="type 1" post="MI [35]. Moreover, inflammation promotes a prothrombotic state, which"/>
  <result pre="related to type 1 MI [35]. Moreover, inflammation promotes a" exact="prothrombotic state," post="which could further increase the risk of microangiopathy in"/>
  <result pre="increase the risk of microangiopathy in multiple organs [36] and" exact="coronary thrombosis" post="at sites of plaque disruption [37]. The inflammatory reaction"/>
  <result pre="the risk of microangiopathy in multiple organs [36] and coronary" exact="thrombosis" post="at sites of plaque disruption [37]. The inflammatory reaction"/>
  <result pre="tissue factor pathway inhibitor, three major coagulation-inhibiting proteins that facilitate" exact="thrombosis" post="[38,39]. Finally, influenza viruses and other viral respiratory infections"/>
  <result pre="proteins that facilitate thrombosis [38,39]. Finally, influenza viruses and other" exact="viral" post="respiratory infections are associated with expression of genes that"/>
  <result pre="that facilitate thrombosis [38,39]. Finally, influenza viruses and other viral" exact="respiratory" post="infections are associated with expression of genes that have"/>
  <result pre="facilitate thrombosis [38,39]. Finally, influenza viruses and other viral respiratory" exact="infections" post="are associated with expression of genes that have been"/>
  <result pre="an increased risk of MI [40]. 2.2. ACS and Other" exact="Acute" post="Respiratory Infections In the early 20th century, an excess"/>
  <result pre="increased risk of MI [40]. 2.2. ACS and Other Acute" exact="Respiratory" post="Infections In the early 20th century, an excess mortality"/>
  <result pre="risk of MI [40]. 2.2. ACS and Other Acute Respiratory" exact="Infections" post="In the early 20th century, an excess mortality during"/>
  <result pre="the early 20th century, an excess mortality during influenza and" exact="pneumonia" post="epidemics was first recognized [41], but the specific association"/>
  <result pre="recognized [41], but the specific association with influenza or other" exact="respiratory" post="infections and MI was not described until decades later"/>
  <result pre="[41], but the specific association with influenza or other respiratory" exact="infections" post="and MI was not described until decades later (see"/>
  <result pre="have documented an increased risk of MI with influenza, pneumonia," exact="acute" post="bronchitis, and other chest infections [42,43,44]. In retrospective and"/>
  <result pre="risk of MI with influenza, pneumonia, acute bronchitis, and other" exact="chest" post="infections [42,43,44]. In retrospective and prospective case series, a"/>
  <result pre="of MI with influenza, pneumonia, acute bronchitis, and other chest" exact="infections" post="[42,43,44]. In retrospective and prospective case series, a rate"/>
  <result pre="8% were found among patients who were hospitalized for community-acquired" exact="pneumonia" post="[45,46]. Other retrospective studies suggested that hospitalization for pneumonia"/>
  <result pre="community-acquired pneumonia [45,46]. Other retrospective studies suggested that hospitalization for" exact="pneumonia" post="was associated with both short and long-term increased risk"/>
  <result pre="studies suggested that hospitalization for pneumonia was associated with both" exact="short" post="and long-term increased risk of CV events; in an"/>
  <result pre="1271 patients (25%) developed CV events over 10 years after" exact="pneumonia" post="hospitalization [47]. A meta-analysis of 10 caseâ€&quot;control studies conducted"/>
  <result pre="two-fold increased risk of AMI in patients with recent influenza" exact="infection" post="or respiratory tract infection; a recent influenza infection, influenza-like"/>
  <result pre="risk of AMI in patients with recent influenza infection or" exact="respiratory" post="tract infection; a recent influenza infection, influenza-like illness, or"/>
  <result pre="tract infection; a recent influenza infection, influenza-like illness, or other" exact="respiratory" post="tract infection was significantly more likely in AMI cases,"/>
  <result pre="a recent influenza infection, influenza-like illness, or other respiratory tract" exact="infection" post="was significantly more likely in AMI cases, with a"/>
  <result pre="confidence interval CI: 1.47 to 2.76) [53]. From a large" exact="American" post="database, among 1, 884, 985 admissions for AMI from"/>
  <result pre="AMI from January 2013 to December 2014, influenza or other" exact="viral" post="respiratory infections accounted for 1.1% of the patients (9885"/>
  <result pre="from January 2013 to December 2014, influenza or other viral" exact="respiratory" post="infections accounted for 1.1% of the patients (9885 and"/>
  <result pre="January 2013 to December 2014, influenza or other viral respiratory" exact="infections" post="accounted for 1.1% of the patients (9885 and 11485"/>
  <result pre="et al. also showed that AMI patients with concomitant influenza" exact="infection" post="or other viral respiratory infections were less likely to"/>
  <result pre="showed that AMI patients with concomitant influenza infection or other" exact="viral" post="respiratory infections were less likely to receive cardiac catheterization"/>
  <result pre="that AMI patients with concomitant influenza infection or other viral" exact="respiratory" post="infections were less likely to receive cardiac catheterization across"/>
  <result pre="AMI patients with concomitant influenza infection or other viral respiratory" exact="infections" post="were less likely to receive cardiac catheterization across all"/>
  <result pre="more than half required revascularization; the rate of revascularization was" exact="lower" post="in those with concomitant influenza than those without, suggesting"/>
  <result pre="undergo cardiac catheterization less, likely due to high risk of" exact="infection" post="spreading. Two other studies have evaluated the prevalence of"/>
  <result pre="infection spreading. Two other studies have evaluated the prevalence of" exact="respiratory" post="infections and influenza among patients with angiographically confirmed MI"/>
  <result pre="spreading. Two other studies have evaluated the prevalence of respiratory" exact="infections" post="and influenza among patients with angiographically confirmed MI [49]"/>
  <result pre="[49] and STEMI [50], respectively. Ruane et al. confirmed that" exact="respiratory" post="infections can trigger MI [50] and Caussin et al."/>
  <result pre="and STEMI [50], respectively. Ruane et al. confirmed that respiratory" exact="infections" post="can trigger MI [50] and Caussin et al. showed"/>
  <result pre="MI), especially considering the association between cTn elevation and sepsis." exact="Acute" post="coronary syndromes and MI were also noted to occur"/>
  <result pre="syndromes and MI were also noted to occur in severe" exact="acute" post="respiratory syndrome (SARS), an infectious disease that afflicted a"/>
  <result pre="and MI were also noted to occur in severe acute" exact="respiratory" post="syndrome (SARS), an infectious disease that afflicted a total"/>
  <result pre="MI were also noted to occur in severe acute respiratory" exact="syndrome" post="(SARS), an infectious disease that afflicted a total of"/>
  <result pre="noted to occur in severe acute respiratory syndrome (SARS), an" exact="infectious disease" post="that afflicted a total of 8096 people in 29"/>
  <result pre="to occur in severe acute respiratory syndrome (SARS), an infectious" exact="disease" post="that afflicted a total of 8096 people in 29"/>
  <result pre="acute respiratory syndrome (SARS), an infectious disease that afflicted a" exact="total" post="of 8096 people in 29 countries in 2003, with"/>
  <result pre="out of 8 patient had subendocardial infarction with occlusive coronary" exact="disease" post="(as well as AMI on presentation with SARS), while"/>
  <result pre="as AMI on presentation with SARS), while 4 patients had" exact="pulmonary" post="thromboembolism and 1 patient developed marantic valvular vegetations, along"/>
  <result pre="vegetations, along with infarction in the heart, kidneys, spleen, and" exact="brain" post="[52]. These findings suggest a possible link between severe"/>
  <result pre="brain [52]. These findings suggest a possible link between severe" exact="acute" post="respiratory syndromes, thrombophilia, and subsequently ACS. Additionally, Middle East"/>
  <result pre="[52]. These findings suggest a possible link between severe acute" exact="respiratory" post="syndromes, thrombophilia, and subsequently ACS. Additionally, Middle East respiratory"/>
  <result pre="acute respiratory syndromes, thrombophilia, and subsequently ACS. Additionally, Middle East" exact="respiratory" post="syndrome (MERS), which was first reported in 2012 in"/>
  <result pre="respiratory syndromes, thrombophilia, and subsequently ACS. Additionally, Middle East respiratory" exact="syndrome" post="(MERS), which was first reported in 2012 in Saudi"/>
  <result pre="diseases, 50% had hypertension, 50% had diabetes, and 16% had" exact="obesity" post="[56]. The clinical risk factors for mortality in MERS"/>
  <result pre="CV-related underlying medical conditions, including hypertension, diabetes, cardiac diseases, and" exact="chronic" post="kidney disease [57,58,59]. Data on the incidence of ACS"/>
  <result pre="underlying medical conditions, including hypertension, diabetes, cardiac diseases, and chronic" exact="kidney disease" post="[57,58,59]. Data on the incidence of ACS in the"/>
  <result pre="medical conditions, including hypertension, diabetes, cardiac diseases, and chronic kidney" exact="disease" post="[57,58,59]. Data on the incidence of ACS in the"/>
  <result pre="on the incidence of ACS in the context of MERS" exact="infection" post="are lacking. Alhogbani reported a case of a 60-year-old"/>
  <result pre="a case of a 60-year-old patient with MERS coronavirus (MERS-CoV)" exact="infection" post="who presented with respiratory symptoms, chest pain, TnT elevation,"/>
  <result pre="60-year-old patient with MERS coronavirus (MERS-CoV) infection who presented with" exact="respiratory" post="symptoms, chest pain, TnT elevation, diffuse T-wave inversion, and"/>
  <result pre="with MERS coronavirus (MERS-CoV) infection who presented with respiratory symptoms," exact="chest" post="pain, TnT elevation, diffuse T-wave inversion, and severe left"/>
  <result pre="infection who presented with respiratory symptoms, chest pain, TnT elevation," exact="diffuse" post="T-wave inversion, and severe left ventricular (LV) dysfunction; acute"/>
  <result pre="elevation, diffuse T-wave inversion, and severe left ventricular (LV) dysfunction;" exact="acute" post="myocarditis was then diagnosed with cardiac magnetic resonance, which"/>
  <result pre="diffuse T-wave inversion, and severe left ventricular (LV) dysfunction; acute" exact="myocarditis" post="was then diagnosed with cardiac magnetic resonance, which excluded"/>
  <result pre="then diagnosed with cardiac magnetic resonance, which excluded an ischemic" exact="cardiomyopathy" post="[60]. A different relative risk of MI with several"/>
  <result pre="cardiomyopathy [60]. A different relative risk of MI with several" exact="respiratory" post="infections has been described by Kwong et al. [43]."/>
  <result pre="[60]. A different relative risk of MI with several respiratory" exact="infections" post="has been described by Kwong et al. [43]. Incidence"/>
  <result pre="within 7 days after detection of influenza B, influenza A," exact="respiratory" post="syncytial virus, and other viruses were 10.11 (95% CI,"/>
  <result pre="al. analyzed the potential relationship between AMI and previous influenza" exact="virus infection," post="and found that AMI was associated with the presence"/>
  <result pre="the presence of IgG antibodies to influenza virus A, B," exact="herpes" post="simplex virus 1 and 2 (HSV1-2), cytomegalovirus (CMV), HSV-1"/>
  <result pre="cytomegalovirus (CMV), HSV-1 and HSV-2, adenovirus (ADV), rhinovirus (RV), and" exact="chlamydia" post="pneumonia with different OR (in particular, adjusted OR for"/>
  <result pre="(CMV), HSV-1 and HSV-2, adenovirus (ADV), rhinovirus (RV), and chlamydia" exact="pneumonia" post="with different OR (in particular, adjusted OR for influenza"/>
  <result pre="[61]. Those findings suggest a stronger correlation between influenza B" exact="virus infection" post="and AMI; however, evidence on the mechanisms that may"/>
  <result pre="Those findings suggest a stronger correlation between influenza B virus" exact="infection" post="and AMI; however, evidence on the mechanisms that may"/>
  <result pre="may lead to different AMI rates in relationship with some" exact="viral" post="infections are lacking. Limitations regarding laboratory testing, baseline characteristics"/>
  <result pre="lead to different AMI rates in relationship with some viral" exact="infections" post="are lacking. Limitations regarding laboratory testing, baseline characteristics (comorbidities"/>
  <result pre="baseline characteristics (comorbidities and vaccinations), and clinical courses of the" exact="infections" post="(mild or severe) may affect the estimation of the"/>
  <result pre="of the absolute risk of AMI during or after different" exact="viral" post="infections. Moreover, the pooled results of the aforementioned meta-analysis"/>
  <result pre="et al. demonstrated an association between influenza vaccination and a" exact="lower" post="risk of composite CV events, with a pooled OR"/>
  <result pre="patients with CAD, reduced their risk of a major adverse" exact="cardiovascular" post="event (MACE) (patients treated with influenza vaccine and MACE"/>
  <result pre="Therefore, current European guidelines on the diagnosis and management of" exact="chronic" post="coronary syndromes recommend annual influenza vaccination in order to"/>
  <result pre="Know Although the clinical manifestations of Covid-19 are dominated by" exact="respiratory" post="symptoms, evidence of myocardial injury was recognized in early"/>
  <result pre="Table 3). Huang et al. first reported a prevalence of" exact="acute" post="myocardial injury of 12% as a major complication among"/>
  <result pre="intensive care unit (ICU) [1]. These findings could suggest that" exact="acute" post="myocardial injury may have a relevant role in worsening"/>
  <result pre="clinical outcomes in Covid-19 patients, even without clear evidence of" exact="myocardial ischemia." post="Indeed, Zhou et al., in a retrospective report of"/>
  <result pre="retrospective report of 191 patients admitted with SARS-Cov-2 pneumonia, diagnosed" exact="acute" post="myocardial injury in 33 out of 191 (17%) patients"/>
  <result pre="Interestingly, they found that non-survivors were more likely to develop" exact="acute" post="myocardial injury than survivors (n = 32, 59% vs."/>
  <result pre="in this cohort was performed on a 53-year-old woman with" exact="chronic" post="renal failure, and findings were consistent with AMI (data"/>
  <result pre="this cohort was performed on a 53-year-old woman with chronic" exact="renal failure," post="and findings were consistent with AMI (data resulting from"/>
  <result pre="Those patients were older, had more CV comorbidities (hypertension, diabetes," exact="cerebrovascular disease," post="and heart failure), and presented with more severe acute"/>
  <result pre="were older, had more CV comorbidities (hypertension, diabetes, cerebrovascular disease," exact="and heart" post="failure), and presented with more severe acute illness than"/>
  <result pre="older, had more CV comorbidities (hypertension, diabetes, cerebrovascular disease, and" exact="heart" post="failure), and presented with more severe acute illness than"/>
  <result pre="cerebrovascular disease, and heart failure), and presented with more severe" exact="acute" post="illness than patients without cardiac injury. This study demonstrated"/>
  <result pre="All ECGs were described as abnormal, with findings compatible with" exact="myocardial ischemia," post="such as T-wave depression and inversion, ST-segment depression, and"/>
  <result pre="abnormal, with findings compatible with myocardial ischemia, such as T-wave" exact="depression" post="and inversion, ST-segment depression, and Q waves. The above"/>
  <result pre="of 416 patients in this cohort (3.36%) may have developed" exact="myocardial ischemia," post="with features consistent with NSTEMI. No evidence of STEMI"/>
  <result pre="evidence of STEMI in this cohort was provided, even if" exact="limited" post="availability of ECGs may have led to underestimation of"/>
  <result pre="Covid-19, 11.8% of patients without underlying CV diseases had substantial" exact="heart" post="damage, showing elevated levels of cTnI or cardiac arrest"/>
  <result pre="had substantial heart damage, showing elevated levels of cTnI or" exact="cardiac arrest" post="during hospitalization [67]. In a meta-analysis by Lippi et"/>
  <result pre="In a meta-analysis by Lippi et al. that included a" exact="total" post="number of 341 patients (123 with severe disease, 36%),"/>
  <result pre="cTnI values were significantly increased in patients with severe SARS-CoV-2" exact="infection" post="compared to those with milder forms of disease [68]."/>
  <result pre="severe SARS-CoV-2 infection compared to those with milder forms of" exact="disease" post="[68]. Several mechanisms that could explain the onset of"/>
  <result pre="disease [68]. Several mechanisms that could explain the onset of" exact="acute" post="myocardial injury related to myocardial ischemia in SARS-CoV-2 infection"/>
  <result pre="could explain the onset of acute myocardial injury related to" exact="myocardial ischemia" post="in SARS-CoV-2 infection have been proposed. Some of them"/>
  <result pre="explain the onset of acute myocardial injury related to myocardial" exact="ischemia" post="in SARS-CoV-2 infection have been proposed. Some of them"/>
  <result pre="of acute myocardial injury related to myocardial ischemia in SARS-CoV-2" exact="infection" post="have been proposed. Some of them may resemble the"/>
  <result pre="Some of them may resemble the ones identified for other" exact="respiratory" post="infectious agents, such a pro-inflammatory state and a cytokine"/>
  <result pre="of them may resemble the ones identified for other respiratory" exact="infectious" post="agents, such a pro-inflammatory state and a cytokine storm"/>
  <result pre="a cytokine storm (which could cause plaque instability), or a" exact="prothrombotic state" post="and hypoxaemia-related damage due to acute respiratory failure. The"/>
  <result pre="instability), or a prothrombotic state and hypoxaemia-related damage due to" exact="acute" post="respiratory failure. The rise in cTn tracks with other"/>
  <result pre="or a prothrombotic state and hypoxaemia-related damage due to acute" exact="respiratory" post="failure. The rise in cTn tracks with other inflammatory"/>
  <result pre="wall motion abnormalities may suggest a different pattern, such as" exact="viral" post="myocarditis and stress cardiomyopathy. The underutilization of coronary angiography"/>
  <result pre="motion abnormalities may suggest a different pattern, such as viral" exact="myocarditis" post="and stress cardiomyopathy. The underutilization of coronary angiography during"/>
  <result pre="of coronary angiography during this outbreak due to the high" exact="infectious" post="risk makes it more difficult to establish a definite"/>
  <result pre="diagnosis in many cases. Furthermore, specific damage caused by SARS-CoV-2" exact="infection" post="might be related to angiotensin-converting enzyme 2 (ACE2) receptors,"/>
  <result pre="(n = 7) and found large delays in presentation after" exact="infection" post="control measures were implemented in their country when compared"/>
  <result pre="EMS, introducing a first â€œCovid-19-related delayâ€� in the so-called â€œtotal" exact="ischemia" post="timeâ€� (Figure 1). Tam et al. also postulated that"/>
  <result pre="to cope with other emergencies such as ACS, due to" exact="limited" post="means of support and healthcare staff, who are either"/>
  <result pre="the remaining hospitals acting as â€œspokesâ€�, in order to gather" exact="cardiovascular" post="emergencies in certain coronary care units (CCUs) all across"/>
  <result pre="and delivering care due to patient fears of contracting an" exact="infection" post="from the healthcare system and longer times taken to"/>
  <result pre="risks related to untimely treatment of ACS patients and SARS-CoV-2" exact="infection" post="control has become a global challenge. Commonly, regional reperfusion"/>
  <result pre="reperfusion strategies are established to maximize efficiency in treatments, since" exact="primary" post="percutaneous coronary intervention (PCI)â€&quot;bypassing the EDâ€&quot;is the routine treatment"/>
  <result pre="patients [79]. Several trials and meta-analyses endorsed by European and" exact="American" post="Guidelines have clearly established the superiority of primary PCI"/>
  <result pre="European and American Guidelines have clearly established the superiority of" exact="primary" post="PCI compared to thrombolysis over the years. As early"/>
  <result pre="outcomes at hospital discharge or at 30 days demonstrated that" exact="primary" post="PCI was superior to thrombolytic therapy for treatment of"/>
  <result pre="30 days or less was 4.4% for patients treated with" exact="primary" post="PCI (n = 1290) compared with 6.5% for patients"/>
  <result pre="patients n = 6763) by Boersma et al. demonstrated that" exact="primary" post="PCI was associated with significantly lower 30-day mortality rate"/>
  <result pre="et al. demonstrated that primary PCI was associated with significantly" exact="lower" post="30-day mortality rate compared to thrombolysis (adjusted OR, 0.63;"/>
  <result pre="with regard to STEMI patients, thrombolytic therapy was recommended over" exact="primary" post="PCI if Covid-19 was confirmed or could not be"/>
  <result pre="Covid-19 was confirmed or could not be excluded within a" exact="short" post="time, while for NSTEMIâ€&quot;UA, the priority was to exclude"/>
  <result pre="time, while for NSTEMIâ€&quot;UA, the priority was to exclude SARS-CoV-2" exact="infection" post="first, since door-to-balloon time is less crucial in those"/>
  <result pre="of prompt reperfusion for the patient, buying time for a" exact="complete" post="diagnosis to be made [84]. According to Pekingâ€™s protocol,"/>
  <result pre="of SARS-CoV-2 nucleic acid before starting treatment, in addition to" exact="chest" post="computed tomography (CT) scanning and evaluation by infectious disease"/>
  <result pre="addition to chest computed tomography (CT) scanning and evaluation by" exact="infectious disease" post="specialists [82]; while Sichuanâ€™s protocol relies on rapid nucleic"/>
  <result pre="to chest computed tomography (CT) scanning and evaluation by infectious" exact="disease" post="specialists [82]; while Sichuanâ€™s protocol relies on rapid nucleic"/>
  <result pre="of SARS-CoV-2 since late February 2020, most â€œhubsâ€� are performing" exact="primary" post="PCI without waiting for screening test results in order"/>
  <result pre="care center (â€œOspedale Luigi Saccoâ€�, Milan, Italy) located in the" exact="heart" post="of the Italian epidemic, no cases of ACS requiring"/>
  <result pre="May 5, 2020, suggesting a possible link between SARS-CoV-2 and" exact="type 2" post="MI or myocarditisâ€&quot;stress cardiomyopathy. A case report from Hu"/>
  <result pre="Hu et al. described a 37-years-old male patient presenting with" exact="chest" post="pain and dyspnea, with ST-segment elevation in the inferior"/>
  <result pre="elevation in the inferior leads, elevation of TnT, and severe" exact="depression" post="of LV ejection fraction (27%), in which an emergency"/>
  <result pre="which an emergency coronary computed tomography angiography (CCTA) revealed no" exact="coronary stenosis" post="and a diagnosis of fulminant myocarditis was made [86]."/>
  <result pre="an emergency coronary computed tomography angiography (CCTA) revealed no coronary" exact="stenosis" post="and a diagnosis of fulminant myocarditis was made [86]."/>
  <result pre="(CCTA) revealed no coronary stenosis and a diagnosis of fulminant" exact="myocarditis" post="was made [86]. Another case report from Inciardi et"/>
  <result pre="a patient infected with SARS-CoV-2 that had severe fatigue, no" exact="chest" post="pain, minimal diffuse ST-segment elevation (more prominent in the"/>
  <result pre="with SARS-CoV-2 that had severe fatigue, no chest pain, minimal" exact="diffuse" post="ST-segment elevation (more prominent in the inferior and lateral"/>
  <result pre="(more prominent in the inferior and lateral leads), an ST-segment" exact="depression" post="with T-wave inversion in lead V1 and aVR, severe"/>
  <result pre="time of urgent coronary angiography, who was then diagnosed with" exact="acute" post="myopericarditis [87]. A first case series from New York"/>
  <result pre="of patients (possibly due to the previously highlighted link between" exact="respiratory" post="infections and type 2 MI), relying on systematic thrombolysis"/>
  <result pre="patients (possibly due to the previously highlighted link between respiratory" exact="infections" post="and type 2 MI), relying on systematic thrombolysis seem"/>
  <result pre="due to the previously highlighted link between respiratory infections and" exact="type 2" post="MI), relying on systematic thrombolysis seem not to be"/>
  <result pre="seem not to be justified from these initial European and" exact="American" post="reports [85,88]. Hence, also based on those findings, the"/>
  <result pre="those findings, the Society for Cardiovascular Angiography and Interventions (SCAI)," exact="American" post="College of Cardiology (ACC), American College of Emergency Physicians"/>
  <result pre="Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC)," exact="American" post="College of Emergency Physicians (ACEP), and American Heart Association"/>
  <result pre="of Cardiology (ACC), American College of Emergency Physicians (ACEP), and" exact="American" post="Heart Association (AHA) published guidance on the management of"/>
  <result pre="Cardiology (ACC), American College of Emergency Physicians (ACEP), and American" exact="Heart" post="Association (AHA) published guidance on the management of AMI"/>
  <result pre="after a first evaluation in the ED to assess the" exact="infectious" post="risks, STEMI patients should undergo primary PCI whenever possible"/>
  <result pre="ED to assess the infectious risks, STEMI patients should undergo" exact="primary" post="PCI whenever possible if it can be provided within"/>
  <result pre="are expected to be longer during the Covid-19 pandemic, a" exact="primary" post="PCI strategy should remain the first choice. Thrombolytic therapy"/>
  <result pre="not be the standard of care strategy and should be" exact="limited" post="to particular situations, such as in non-PCI capable hospital"/>
  <result pre="Those latest recommendations are more consistent with general European and" exact="American" post="Guidelines on STEMI [70,91], confirming that primary PCI remains"/>
  <result pre="general European and American Guidelines on STEMI [70,91], confirming that" exact="primary" post="PCI remains the reperfusion therapy of choice if feasible"/>
  <result pre="adequate safety measures to protect healthcare workers (see after), since" exact="primary" post="PCI should remain the default strategy in patients with"/>
  <result pre="with clear evidence of a STEMI, as clearly stated in" exact="American" post="guidelines on the management of AMI during the Covid-19"/>
  <result pre="of Interventional Cardiology (CAIC) announced the formation of the North" exact="American" post="Covid-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI) [92], which"/>
  <result pre="the formation of the North American Covid-19 ST-Segment Elevation Myocardial" exact="Infarction" post="Registry (NACMI) [92], which hopefully will tell us more"/>
  <result pre="especially during this outbreak, which is seeing high rates of" exact="infections" post="among healthcare personnel [96], this setting-up may contribute to"/>
  <result pre="normal or positive ventilation systems and are not designed for" exact="infection" post="isolation, meaning that terminals must be cleaned following the"/>
  <result pre="randomized, controlled, open-label trial conducted by Cao et al., hospitalized" exact="adult" post="patients with severe Covid-19 showed no benefit with lopinavirâ€&quot;ritonavir"/>
  <result pre="pandemic [102], no evidence of severe adverse events, long-term survival," exact="acute" post="health care utilization, or quality of life in patients"/>
  <result pre="inhibition [104] and the potential role of hydroxychloroquine in reducing" exact="heart" post="rate [105]. Reninâ€&quot;angiotensinâ€&quot;aldosterone system (RAAS)-related drugs (such as ACE"/>
  <result pre="early mortality [106]. Despite a lack of evidence of drug" exact="consumption" post="or discontinuation in these patients included in the previous"/>
  <result pre="of RAAS inhibitors in high-risk patients, especially those who have" exact="heart" post="failure or previous MI, may result in clinical instability"/>
  <result pre="be related to myocardial injury. Antivirals drugs used for SARS-CoV-2" exact="infection" post="treatment may have potential interactions with oral anticoagulants (OACs)."/>
  <result pre="evidence showed decreased mortality in most severe Covid-19 patients with" exact="coagulopathy" post="[111]. Drugs that are potentially useful for treatment of"/>
  <result pre="coagulopathy [111]. Drugs that are potentially useful for treatment of" exact="acute" post="coronary syndromes and coronary artery disease and their potential"/>
  <result pre="are potentially useful for treatment of acute coronary syndromes and" exact="coronary artery disease" post="and their potential interactions are summarized in Table 4."/>
  <result pre="potentially useful for treatment of acute coronary syndromes and coronary" exact="artery disease" post="and their potential interactions are summarized in Table 4."/>
  <result pre="useful for treatment of acute coronary syndromes and coronary artery" exact="disease" post="and their potential interactions are summarized in Table 4."/>
  <result pre="Table 4. 4. Conclusions Despite being eclipsed by Covid-19 outbreak," exact="acute" post="coronary syndromes are still a major cause of morbidity"/>
  <result pre="possible physiopathological links (currently unexplored) with SARS-CoV-2 infection. Given the" exact="limited" post="heterogeneity of data published in recent months, the potential"/>
  <result pre="in Covid-19 may be related more to myocardial injury or" exact="type 2" post="MI than to type 1 MI, consistent with our"/>
  <result pre="more to myocardial injury or type 2 MI than to" exact="type 1" post="MI, consistent with our analysis, more data are needed"/>
  <result pre="reperfusion therapy should not be forgotten. Specific protocols to balance" exact="infective" post="risks related to Covid-19 and optimal ACS management should"/>
  <result pre="during the Covid-19 pandemic due to their expertise in treating" exact="coronary artery disease" post="and myocardial infarction. M.G. provided expert commentary on links"/>
  <result pre="the Covid-19 pandemic due to their expertise in treating coronary" exact="artery disease" post="and myocardial infarction. M.G. provided expert commentary on links"/>
  <result pre="Covid-19 pandemic due to their expertise in treating coronary artery" exact="disease" post="and myocardial infarction. M.G. provided expert commentary on links"/>
  <result pre="due to their expertise in treating coronary artery disease and" exact="myocardial infarction." post="M.G. provided expert commentary on links between respiratory infections"/>
  <result pre="and myocardial infarction. M.G. provided expert commentary on links between" exact="respiratory" post="infections and myocardial involvement, and on infectious risk in"/>
  <result pre="myocardial infarction. M.G. provided expert commentary on links between respiratory" exact="infections" post="and myocardial involvement, and on infectious risk in ischemic"/>
  <result pre="on links between respiratory infections and myocardial involvement, and on" exact="infectious" post="risk in ischemic patients during Covid-19 pandemic due to"/>
  <result pre="ischemic patients during Covid-19 pandemic due to his expertise in" exact="infectious disease." post="G.B.-Z., F.D., A.P., A.G., G.M., M.V., M.G., F.F., M.M.,"/>
  <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA J. Am. Med. Assoc.20203231061106910.1001/jama.2020.158532031570 2.LivingstonE.BucherK.Coronavirus Disease"/>
  <result pre="coronavirus-infected pneumonia in Wuhan, ChinaJAMA J. Am. Med. Assoc.20203231061106910.1001/jama.2020.158532031570 2.LivingstonE.BucherK.Coronavirus" exact="Disease" post="2019 (COVID-19) in ItalyJAMA202010.1001/jama.2020.4344 3.HolshueM.L.DeBoltC.LindquistS.LofyK.H.WiesmanJ.BruceH.SpittersC.EricsonK.WilkersonS.TuralA.et al.First case of 2019"/>
  <result pre="novel coronavirus in the United StatesN. Engl. J. Med.202010.1056/NEJMoa200119132004427 4.Coronavirus" exact="Disease" post="2019 (COVID-19) Situation Reportâ€&quot;105Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200504-covid-19-sitrep-105.pdf?sfvrsn=4cdda8af_2(accessed on 5 May"/>
  <result pre="Cardiol.202010.1001/jamacardio.2020.095032211816 7.GuoT.FanY.ChenM.WuX.ZhangL.HeT.WangH.WanJ.WangX.LuZ.Cardiovascular implications of fatal outcomes of patients with coronavirus" exact="disease" post="2019 (COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732219356 8.RemuzziA.RemuzziG.COVID-19 and Italy: What next?Lancet20203951225122810.1016/S0140-6736(20)30627-932178769 9.EisenA.GiuglianoR.P.BraunwaldE.Updates"/>
  <result pre="2019 (COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732219356 8.RemuzziA.RemuzziG.COVID-19 and Italy: What next?Lancet20203951225122810.1016/S0140-6736(20)30627-932178769 9.EisenA.GiuglianoR.P.BraunwaldE.Updates on" exact="acute" post="coronary syndrome: A reviewJAMA Cardiol.2016171873010.1001/jamacardio.2016.204927438381 10.TownsendN.WilsonL.BhatnagarP.WickramasingheK.RaynerM.NicholsM.Cardiovascular disease in Europe:"/>
  <result pre="next?Lancet20203951225122810.1016/S0140-6736(20)30627-932178769 9.EisenA.GiuglianoR.P.BraunwaldE.Updates on acute coronary syndrome: A reviewJAMA Cardiol.2016171873010.1001/jamacardio.2016.204927438381 10.TownsendN.WilsonL.BhatnagarP.WickramasingheK.RaynerM.NicholsM.Cardiovascular" exact="disease" post="in Europe: Epidemiological update 2016Eur. Heart J.2016373232324510.1093/eurheartj/ehw33427523477 11.AmsterdamE.A.WengerN.K.BrindisR.G.CaseyD.E.GaniatsT.G.HolmesD.R.JaffeA.S.JneidH.KellyR.F.KontosM.C.et al.2014"/>
  <result pre="A reviewJAMA Cardiol.2016171873010.1001/jamacardio.2016.204927438381 10.TownsendN.WilsonL.BhatnagarP.WickramasingheK.RaynerM.NicholsM.Cardiovascular disease in Europe: Epidemiological update 2016Eur." exact="Heart" post="J.2016373232324510.1093/eurheartj/ehw33427523477 11.AmsterdamE.A.WengerN.K.BrindisR.G.CaseyD.E.GaniatsT.G.HolmesD.R.JaffeA.S.JneidH.KellyR.F.KontosM.C.et al.2014 AHA/ACC guideline for the management of"/>
  <result pre="al.2014 AHA/ACC guideline for the management of patients with non-st-elevation" exact="acute" post="coronary syndromes: A report of the American college of"/>
  <result pre="patients with non-st-elevation acute coronary syndromes: A report of the" exact="American" post="college of cardiology/American heart association task force on practice"/>
  <result pre="coronary syndromes: A report of the American college of cardiology/American" exact="heart" post="association task force on practice guidelinesCirculation2014130e344e42625249585 12.RoffiM.PatronoC.ColletJ.P.MuellerC.ValgimigliM.AndreottiF.BaxJ.J.BorgerM.A.BrotonsC.ChewD.P.et al.2015 ESC"/>
  <result pre="practice guidelinesCirculation2014130e344e42625249585 12.RoffiM.PatronoC.ColletJ.P.MuellerC.ValgimigliM.AndreottiF.BaxJ.J.BorgerM.A.BrotonsC.ChewD.P.et al.2015 ESC Guidelines for the management of" exact="acute" post="coronary syndromes in patients presenting without persistent st-segment elevation:"/>
  <result pre="without persistent st-segment elevation: Task force for the management of" exact="acute" post="coronary syndromes in patients presenting without persistent ST-segment elevation"/>
  <result pre="persistent ST-segment elevation of the European Society of Cardiology (ESC)Eur." exact="Heart" post="J.20163726731526320110 13.ThygesenK.AlpertJ.S.JaffeA.S.ChaitmanB.R.BaxJ.J.MorrowD.A.WhiteH.D.MickleyH.CreaF.Van De WerfF.et al.Fourth universal definition of myocardial"/>
  <result pre="(ESC)Eur. Heart J.20163726731526320110 13.ThygesenK.AlpertJ.S.JaffeA.S.ChaitmanB.R.BaxJ.J.MorrowD.A.WhiteH.D.MickleyH.CreaF.Van De WerfF.et al.Fourth universal definition of" exact="myocardial infarction" post="(2018)Eur. Heart J.20194023726910.1093/eurheartj/ehy462 14.ThygesenK.MairJ.KatusH.PlebaniM.VengeP.CollinsonP.LindahlB.GiannitsisE.HasinY.GalvaniM.et al.Recommendations for the use of"/>
  <result pre="13.ThygesenK.AlpertJ.S.JaffeA.S.ChaitmanB.R.BaxJ.J.MorrowD.A.WhiteH.D.MickleyH.CreaF.Van De WerfF.et al.Fourth universal definition of myocardial infarction (2018)Eur." exact="Heart" post="J.20194023726910.1093/eurheartj/ehy462 14.ThygesenK.MairJ.KatusH.PlebaniM.VengeP.CollinsonP.LindahlB.GiannitsisE.HasinY.GalvaniM.et al.Recommendations for the use of cardiac troponin"/>
  <result pre="14.ThygesenK.MairJ.KatusH.PlebaniM.VengeP.CollinsonP.LindahlB.GiannitsisE.HasinY.GalvaniM.et al.Recommendations for the use of cardiac troponin measurement in" exact="acute" post="cardiac careEur. Heart J.2010312197220410.1093/eurheartj/ehq25120685679 15.JanuzziJ.L.SandovalY.The many faces of type"/>
  <result pre="the use of cardiac troponin measurement in acute cardiac careEur." exact="Heart" post="J.2010312197220410.1093/eurheartj/ehq25120685679 15.JanuzziJ.L.SandovalY.The many faces of type 2 myocardial infarctionJ."/>
  <result pre="in acute cardiac careEur. Heart J.2010312197220410.1093/eurheartj/ehq25120685679 15.JanuzziJ.L.SandovalY.The many faces of" exact="type 2" post="myocardial infarctionJ. Am. Coll. Cardiol.2017701569157210.1016/j.jacc.2017.07.78428935033 16.SmilowitzN.R.WeissM.C.MauricioR.MahajanA.M.DuganK.E.DevanabandaA.PulgarinC.GianosE.ShahB.SedlisS.P.et al.Provoking conditions, management"/>
  <result pre="Am. Coll. Cardiol.2017701569157210.1016/j.jacc.2017.07.78428935033 16.SmilowitzN.R.WeissM.C.MauricioR.MahajanA.M.DuganK.E.DevanabandaA.PulgarinC.GianosE.ShahB.SedlisS.P.et al.Provoking conditions, management and outcomes of" exact="type 2" post="myocardial infarction and myocardial necrosisInt. J. Cardiol.201610.1016/j.ijcard.2016.05.045 17.SteinG.Y.HerscoviciG.KorenfeldR.MatetzkyS.GottliebS.AlonD.Gevrielov-YusimN.IakobishviliZ.FuchsS.Type-II myocardial"/>
  <result pre="Cardiol.2017701569157210.1016/j.jacc.2017.07.78428935033 16.SmilowitzN.R.WeissM.C.MauricioR.MahajanA.M.DuganK.E.DevanabandaA.PulgarinC.GianosE.ShahB.SedlisS.P.et al.Provoking conditions, management and outcomes of type 2" exact="myocardial infarction" post="and myocardial necrosisInt. J. Cardiol.201610.1016/j.ijcard.2016.05.045 17.SteinG.Y.HerscoviciG.KorenfeldR.MatetzkyS.GottliebS.AlonD.Gevrielov-YusimN.IakobishviliZ.FuchsS.Type-II myocardial infarctionâ€&quot;Patient characteristics,"/>
  <result pre="ONE201410.1371/journal.pone.0084285 18.LippiG.Sanchis-GomarF.CervellinG.Chest pain, dyspnea and other symptoms in patients with" exact="type 1" post="and 2 myocardial infarction. A literature reviewInt. J. Cardiol.201610.1016/j.ijcard.2016.04.045"/>
  <result pre="and other symptoms in patients with type 1 and 2" exact="myocardial infarction." post="A literature reviewInt. J. Cardiol.201610.1016/j.ijcard.2016.04.045 19.SandovalY.SmithS.W.SexterA.SchulzK.AppleF.S.Use of objective evidence"/>
  <result pre="A literature reviewInt. J. Cardiol.201610.1016/j.ijcard.2016.04.045 19.SandovalY.SmithS.W.SexterA.SchulzK.AppleF.S.Use of objective evidence of" exact="myocardial ischemia" post="to facilitate the diagnostic and prognostic distinction between type"/>
  <result pre="literature reviewInt. J. Cardiol.201610.1016/j.ijcard.2016.04.045 19.SandovalY.SmithS.W.SexterA.SchulzK.AppleF.S.Use of objective evidence of myocardial" exact="ischemia" post="to facilitate the diagnostic and prognostic distinction between type"/>
  <result pre="myocardial ischemia to facilitate the diagnostic and prognostic distinction between" exact="type 2" post="myocardial infarction and myocardial injuryEur. Hear. J. Acute Cardiovasc."/>
  <result pre="to facilitate the diagnostic and prognostic distinction between type 2" exact="myocardial infarction" post="and myocardial injuryEur. Hear. J. Acute Cardiovasc. Care20209626910.1177/2048872618787796 20.SandovalY.ThygesenK.Myocardial"/>
  <result pre="between type 2 myocardial infarction and myocardial injuryEur. Hear. J." exact="Acute" post="Cardiovasc. Care20209626910.1177/2048872618787796 20.SandovalY.ThygesenK.Myocardial infarction type 2 and myocardial injuryClin."/>
  <result pre="and myocardial injuryEur. Hear. J. Acute Cardiovasc. Care20209626910.1177/2048872618787796 20.SandovalY.ThygesenK.Myocardial infarction" exact="type 2" post="and myocardial injuryClin. Chem.20176310110710.1373/clinchem.2016.25552128062614 21.ArlatiS.CasellaG.P.LanzaniM.BrennaS.PrencipeL.MarocchiA.GandiniC.Myocardial necrosis in ICU patients"/>
  <result pre="and myocardial injuryClin. Chem.20176310110710.1373/clinchem.2016.25552128062614 21.ArlatiS.CasellaG.P.LanzaniM.BrennaS.PrencipeL.MarocchiA.GandiniC.Myocardial necrosis in ICU patients with" exact="acute" post="non-cardiac disease: A prospective studyIntensive Care Med.200026313710.1007/s00134005000810663277 22.MusherD.M.AbersM.S.Corrales-MedinaV.F.Acute infection"/>
  <result pre="with acute non-cardiac disease: A prospective studyIntensive Care Med.200026313710.1007/s00134005000810663277 22.MusherD.M.AbersM.S.Corrales-MedinaV.F.Acute" exact="infection" post="and myocardial infarctionN. Engl. J. Med.201938017117610.1056/NEJMra180813730625066 23.KochiA.N.TagliariA.P.ForleoG.B.FassiniG.M.TondoC.Cardiac and arrhythmic"/>
  <result pre="Topic of the WeekJ. Am. Coll. Cardiol.2019731846186010.1016/j.jacc.2019.02.01830975302 25.DavidsonJ.A.Warren-GashC.Cardiovascular complications of" exact="acute" post="respiratory infections: Current research and future directionsExpert Rev. Anti."/>
  <result pre="of the WeekJ. Am. Coll. Cardiol.2019731846186010.1016/j.jacc.2019.02.01830975302 25.DavidsonJ.A.Warren-GashC.Cardiovascular complications of acute" exact="respiratory" post="infections: Current research and future directionsExpert Rev. Anti. Infect.20191793994210.1080/14787210.2019.168981731684779"/>
  <result pre="Frequently Unrecognized ComplicationJAMA J. Am. Med. Assoc.19952731945194910.1001/jama.1995.03520480065042 27.KarpickR.J.PrattP.C.AsmundssonT.KilburnK.H.Pathological findings in" exact="respiratory" post="failure. Goblet cell metaplasia, alveolar damage, and myocardial infarctionAnn."/>
  <result pre="Intern. Med.19707218919710.7326/0003-4819-72-2-1895412486 28.SoeiroA.d.M.RuppertA.D.CanzianM.CapelozziV.L.SerranoC.V.Postmortem diagnosis of Acutemyocardial infarction in patients with" exact="acute" post="respiratory failure - Demographics, etiologic and pulmonary Histologic analysisClinics201210.6061/clinics/2012(03)02"/>
  <result pre="Med.19707218919710.7326/0003-4819-72-2-1895412486 28.SoeiroA.d.M.RuppertA.D.CanzianM.CapelozziV.L.SerranoC.V.Postmortem diagnosis of Acutemyocardial infarction in patients with acute" exact="respiratory" post="failure - Demographics, etiologic and pulmonary Histologic analysisClinics201210.6061/clinics/2012(03)02 29.StaryH.C.ChandlerA.B.DinsmoreR.E.FusterV.GlagovS.InsullW.RosenfeldM.E.SchwartzC.J.WagnerW.D.WisslerR.W.A"/>
  <result pre="in patients with acute respiratory failure - Demographics, etiologic and" exact="pulmonary" post="Histologic analysisClinics201210.6061/clinics/2012(03)02 29.StaryH.C.ChandlerA.B.DinsmoreR.E.FusterV.GlagovS.InsullW.RosenfeldM.E.SchwartzC.J.WagnerW.D.WisslerR.W.A definition of advanced types of atherosclerotic"/>
  <result pre="histological classification of atherosclerosis: A report from the Committee on" exact="Vascular" post="Lesions of the council on arteriosclerosis, American heart associationCirculation1995921355137410.1161/01.CIR.92.5.13557648691"/>
  <result pre="the Committee on Vascular Lesions of the council on arteriosclerosis," exact="American" post="heart associationCirculation1995921355137410.1161/01.CIR.92.5.13557648691 30.MaurielloA.SangiorgiG.FratoniS.PalmieriG.BonannoE.AnemonaL.SchwartzR.S.SpagnoliL.G.Diffuse and active inflammation occurs in both"/>
  <result pre="Committee on Vascular Lesions of the council on arteriosclerosis, American" exact="heart" post="associationCirculation1995921355137410.1161/01.CIR.92.5.13557648691 30.MaurielloA.SangiorgiG.FratoniS.PalmieriG.BonannoE.AnemonaL.SchwartzR.S.SpagnoliL.G.Diffuse and active inflammation occurs in both vulnerable"/>
  <result pre="associationCirculation1995921355137410.1161/01.CIR.92.5.13557648691 30.MaurielloA.SangiorgiG.FratoniS.PalmieriG.BonannoE.AnemonaL.SchwartzR.S.SpagnoliL.G.Diffuse and active inflammation occurs in both vulnerable and" exact="stable" post="plaques of the entire coronary tree: A histopathologic study"/>
  <result pre="entire coronary tree: A histopathologic study of patients dying of" exact="acute" post="myocardial infarctionJ. Am. Coll. Cardiol.2005451585159310.1016/j.jacc.2005.01.05415893171 31.KaynarA.M.YendeS.ZhuL.FrederickD.R.ChambersR.BurtonC.L.CarterM.StolzD.B.AgostiniB.GregoryA.D.et al.Effects of intra-abdominal"/>
  <result pre="infarctionJ. Am. Coll. Cardiol.2005451585159310.1016/j.jacc.2005.01.05415893171 31.KaynarA.M.YendeS.ZhuL.FrederickD.R.ChambersR.BurtonC.L.CarterM.StolzD.B.AgostiniB.GregoryA.D.et al.Effects of intra-abdominal sepsis on" exact="atherosclerosis" post="in miceCrit. Care20141810.1186/s13054-014-0469-1 32.MadjidM.VelaD.Khalili-TabriziH.CasscellsS.W.LitovskyS.Systemic infections cause exaggerated local inflammation"/>
  <result pre="al.Effects of intra-abdominal sepsis on atherosclerosis in miceCrit. Care20141810.1186/s13054-014-0469-1 32.MadjidM.VelaD.Khalili-TabriziH.CasscellsS.W.LitovskyS.Systemic" exact="infections" post="cause exaggerated local inflammation in atherosclerotic coronary arteries: Clues"/>
  <result pre="in atherosclerotic coronary arteries: Clues to the triggering effect of" exact="acute" post="infections on acute coronary syndromesTex. Heart Inst. J.200734111817420787 33.CreaF.LiuzzoG.Pathogenesis"/>
  <result pre="atherosclerotic coronary arteries: Clues to the triggering effect of acute" exact="infections" post="on acute coronary syndromesTex. Heart Inst. J.200734111817420787 33.CreaF.LiuzzoG.Pathogenesis of"/>
  <result pre="arteries: Clues to the triggering effect of acute infections on" exact="acute" post="coronary syndromesTex. Heart Inst. J.200734111817420787 33.CreaF.LiuzzoG.Pathogenesis of acute coronary"/>
  <result pre="the triggering effect of acute infections on acute coronary syndromesTex." exact="Heart" post="Inst. J.200734111817420787 33.CreaF.LiuzzoG.Pathogenesis of acute coronary syndromesJ. Am. Coll."/>
  <result pre="infections on acute coronary syndromesTex. Heart Inst. J.200734111817420787 33.CreaF.LiuzzoG.Pathogenesis of" exact="acute" post="coronary syndromesJ. Am. Coll. Cardiol.20136111110.1016/j.jacc.2012.07.06423158526 34.LibbyP.Mechanisms of acute coronary"/>
  <result pre="33.CreaF.LiuzzoG.Pathogenesis of acute coronary syndromesJ. Am. Coll. Cardiol.20136111110.1016/j.jacc.2012.07.06423158526 34.LibbyP.Mechanisms of" exact="acute" post="coronary syndromes and their implications for therapyN. Engl. J."/>
  <result pre="their implications for therapyN. Engl. J. Med.20133682004201310.1056/NEJMra121606323697515 35.FusterV.BadimonL.BadimonJ.J.ChesebroJ.H.EpsteinF.H.The pathogenesis of" exact="coronary artery disease" post="and the acute coronary syndromesN. Engl. J. Med.19923262422501727977 36.LiuP.P.BletA.SmythD.LiH.The"/>
  <result pre="implications for therapyN. Engl. J. Med.20133682004201310.1056/NEJMra121606323697515 35.FusterV.BadimonL.BadimonJ.J.ChesebroJ.H.EpsteinF.H.The pathogenesis of coronary" exact="artery disease" post="and the acute coronary syndromesN. Engl. J. Med.19923262422501727977 36.LiuP.P.BletA.SmythD.LiH.The"/>
  <result pre="for therapyN. Engl. J. Med.20133682004201310.1056/NEJMra121606323697515 35.FusterV.BadimonL.BadimonJ.J.ChesebroJ.H.EpsteinF.H.The pathogenesis of coronary artery" exact="disease" post="and the acute coronary syndromesN. Engl. J. Med.19923262422501727977 36.LiuP.P.BletA.SmythD.LiH.The"/>
  <result pre="J. Med.20133682004201310.1056/NEJMra121606323697515 35.FusterV.BadimonL.BadimonJ.J.ChesebroJ.H.EpsteinF.H.The pathogenesis of coronary artery disease and the" exact="acute" post="coronary syndromesN. Engl. J. Med.19923262422501727977 36.LiuP.P.BletA.SmythD.LiH.The Science Underlying COVID-19:"/>
  <result pre="Engl. J. Med.19923262422501727977 36.LiuP.P.BletA.SmythD.LiH.The Science Underlying COVID-19: Implications for the" exact="cardiovascular" post="systemCirculation202010.1161/CIRCULATIONAHA.120.047549 37.HarskampR.E.Van GinkelM.W.Acute respiratory tract infections: A potential trigger"/>
  <result pre="Science Underlying COVID-19: Implications for the cardiovascular systemCirculation202010.1161/CIRCULATIONAHA.120.047549 37.HarskampR.E.Van GinkelM.W.Acute" exact="respiratory" post="tract infections: A potential trigger for the acute coronary"/>
  <result pre="37.HarskampR.E.Van GinkelM.W.Acute respiratory tract infections: A potential trigger for the" exact="acute" post="coronary syndromeAnn. Med.20084012112810.1080/0785389070175367218293142 38.KellerT.T.MairuhuA.T.A.De KruifM.D.KleinS.K.GerdesV.E.A.Ten CateH.BrandjesD.P.M.LeviM.Van GorpE.C.M.Infections and endothelial"/>
  <result pre="PollT.BÃ¼llerH.R.Bidirectional relation between inflammation and coagulationCirculation20041092698270410.1161/01.CIR.0000131660.51520.9A15184294 40.RoseJ.J.VooraD.CyrD.D.LucasJ.E.ZaasA.K.WoodsC.W.NewbyL.K.KrausW.E.GinsburgG.S.Gene expression profiles link" exact="respiratory" post="viral infection, platelet response to aspirin, and acute myocardial"/>
  <result pre="relation between inflammation and coagulationCirculation20041092698270410.1161/01.CIR.0000131660.51520.9A15184294 40.RoseJ.J.VooraD.CyrD.D.LucasJ.E.ZaasA.K.WoodsC.W.NewbyL.K.KrausW.E.GinsburgG.S.Gene expression profiles link respiratory" exact="viral infection," post="platelet response to aspirin, and acute myocardial infarctionPLoS ONE201510e013225910.1371/journal.pone.013225926193668"/>
  <result pre="profiles link respiratory viral infection, platelet response to aspirin, and" exact="acute" post="myocardial infarctionPLoS ONE201510e013225910.1371/journal.pone.013225926193668 41.CollinsS.D.Excess mortality from causes other than"/>
  <result pre="infarctionPLoS ONE201510e013225910.1371/journal.pone.013225926193668 41.CollinsS.D.Excess mortality from causes other than influenza and" exact="pneumonia" post="during influenza epidemicsPublic Health Rep.193210.2307/4580606 42.SmeethL.ThomasS.L.HallA.J.HubbardR.FarringtonP.VallanceP.Risk of myocardial infarction"/>
  <result pre="influenza and pneumonia during influenza epidemicsPublic Health Rep.193210.2307/4580606 42.SmeethL.ThomasS.L.HallA.J.HubbardR.FarringtonP.VallanceP.Risk of" exact="myocardial infarction" post="and stroke after acute infection or vaccinationN. Engl. J."/>
  <result pre="during influenza epidemicsPublic Health Rep.193210.2307/4580606 42.SmeethL.ThomasS.L.HallA.J.HubbardR.FarringtonP.VallanceP.Risk of myocardial infarction and" exact="stroke" post="after acute infection or vaccinationN. Engl. J. Med.200410.1056/NEJMoa04174715602021 43.KwongJ.C.SchwartzK.L.CampitelliM.A.ChungH.CrowcroftN.S.KarnauchowT.KatzK.KoD.T.McGeerA.J.McNallyD.et"/>
  <result pre="epidemicsPublic Health Rep.193210.2307/4580606 42.SmeethL.ThomasS.L.HallA.J.HubbardR.FarringtonP.VallanceP.Risk of myocardial infarction and stroke after" exact="acute" post="infection or vaccinationN. Engl. J. Med.200410.1056/NEJMoa04174715602021 43.KwongJ.C.SchwartzK.L.CampitelliM.A.ChungH.CrowcroftN.S.KarnauchowT.KatzK.KoD.T.McGeerA.J.McNallyD.et al.Acute myocardial"/>
  <result pre="Health Rep.193210.2307/4580606 42.SmeethL.ThomasS.L.HallA.J.HubbardR.FarringtonP.VallanceP.Risk of myocardial infarction and stroke after acute" exact="infection" post="or vaccinationN. Engl. J. Med.200410.1056/NEJMoa04174715602021 43.KwongJ.C.SchwartzK.L.CampitelliM.A.ChungH.CrowcroftN.S.KarnauchowT.KatzK.KoD.T.McGeerA.J.McNallyD.et al.Acute myocardial infarction"/>
  <result pre="after acute infection or vaccinationN. Engl. J. Med.200410.1056/NEJMoa04174715602021 43.KwongJ.C.SchwartzK.L.CampitelliM.A.ChungH.CrowcroftN.S.KarnauchowT.KatzK.KoD.T.McGeerA.J.McNallyD.et al.Acute" exact="myocardial infarction" post="after laboratory-confirmed influenza infectionN. Engl. J. Med.201810.1056/NEJMoa170209029365305 44.Warren-GashC.GerettiA.M.HamiltonG.RakhitR.D.SmeethL.HaywardA.C.Influenza-like illness"/>
  <result pre="after laboratory-confirmed influenza infectionN. Engl. J. Med.201810.1056/NEJMoa170209029365305 44.Warren-GashC.GerettiA.M.HamiltonG.RakhitR.D.SmeethL.HaywardA.C.Influenza-like illness in" exact="acute" post="myocardial infarction patients during the winter wave of the"/>
  <result pre="laboratory-confirmed influenza infectionN. Engl. J. Med.201810.1056/NEJMoa170209029365305 44.Warren-GashC.GerettiA.M.HamiltonG.RakhitR.D.SmeethL.HaywardA.C.Influenza-like illness in acute" exact="myocardial infarction" post="patients during the winter wave of the influenza A"/>
  <result pre="mortality risk in community-acquired pneumoniaClin. Infect. Dis.2017641486149310.1093/cid/cix16428205683 46.MusherD.M.RuedaA.M.KakaA.S.MaparaS.M.The Association between" exact="Pneumococcal" post="Pneumonia and Acute Cardiac EventsClin. Infect. Dis.200710.1086/518849 47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association"/>
  <result pre="risk in community-acquired pneumoniaClin. Infect. Dis.2017641486149310.1093/cid/cix16428205683 46.MusherD.M.RuedaA.M.KakaA.S.MaparaS.M.The Association between Pneumococcal" exact="Pneumonia" post="and Acute Cardiac EventsClin. Infect. Dis.200710.1086/518849 47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association between"/>
  <result pre="community-acquired pneumoniaClin. Infect. Dis.2017641486149310.1093/cid/cix16428205683 46.MusherD.M.RuedaA.M.KakaA.S.MaparaS.M.The Association between Pneumococcal Pneumonia and" exact="Acute" post="Cardiac EventsClin. Infect. Dis.200710.1086/518849 47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association between hospitalization for"/>
  <result pre="pneumoniaClin. Infect. Dis.2017641486149310.1093/cid/cix16428205683 46.MusherD.M.RuedaA.M.KakaA.S.MaparaS.M.The Association between Pneumococcal Pneumonia and Acute" exact="Cardiac" post="EventsClin. Infect. Dis.200710.1086/518849 47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association between hospitalization for pneumonia"/>
  <result pre="Acute Cardiac EventsClin. Infect. Dis.200710.1086/518849 47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association between hospitalization for" exact="pneumonia" post="and subsequent risk of cardiovascular diseaseJAMA J. Am. Med."/>
  <result pre="47.Corrales-MedinaV.F.AlvarezK.N.WeissfeldL.A.AngusD.C.ChirinosJ.A.ChangC.C.H.NewmanA.LoehrL.FolsomA.R.ElkindM.S.et al.Association between hospitalization for pneumonia and subsequent risk of" exact="cardiovascular" post="diseaseJAMA J. Am. Med. Assoc.201510.1001/jama.2014.18229 48.VejpongsaP.KitkungvanD.MadjidM.CharitakisK.AndersonH.V.ArainS.BalanP.SmallingR.W.DhobleA.Outcomes of acute myocardial"/>
  <result pre="risk of cardiovascular diseaseJAMA J. Am. Med. Assoc.201510.1001/jama.2014.18229 48.VejpongsaP.KitkungvanD.MadjidM.CharitakisK.AndersonH.V.ArainS.BalanP.SmallingR.W.DhobleA.Outcomes of" exact="acute" post="myocardial infarction in patients with influenza and other viral"/>
  <result pre="of cardiovascular diseaseJAMA J. Am. Med. Assoc.201510.1001/jama.2014.18229 48.VejpongsaP.KitkungvanD.MadjidM.CharitakisK.AndersonH.V.ArainS.BalanP.SmallingR.W.DhobleA.Outcomes of acute" exact="myocardial infarction" post="in patients with influenza and other viral respiratory infectionsAm."/>
  <result pre="of acute myocardial infarction in patients with influenza and other" exact="viral" post="respiratory infectionsAm. J. Med.20191321173118110.1016/j.amjmed.2019.05.00231145880 49.CaussinC.EscolanoS.MustaficH.BatailleS.TaffletM.ChatignouxE.LambertY.BenamerH.GarotP.JabreP.et al.Short-term exposure to environmental"/>
  <result pre="acute myocardial infarction in patients with influenza and other viral" exact="respiratory" post="infectionsAm. J. Med.20191321173118110.1016/j.amjmed.2019.05.00231145880 49.CaussinC.EscolanoS.MustaficH.BatailleS.TaffletM.ChatignouxE.LambertY.BenamerH.GarotP.JabreP.et al.Short-term exposure to environmental parameters"/>
  <result pre="al.Short-term exposure to environmental parameters and onset of ST elevation" exact="myocardial infarction." post="The CARDIO-ARSIF registryInt. J. Cardiol.2015183172310.1016/j.ijcard.2015.01.07825662048 50.RuaneL.BuckleyT.HooS.Y.S.HansenP.S.McCormackC.ShawE.FethneyJ.ToflerG.H.Triggering of acute myocardial"/>
  <result pre="elevation myocardial infarction. The CARDIO-ARSIF registryInt. J. Cardiol.2015183172310.1016/j.ijcard.2015.01.07825662048 50.RuaneL.BuckleyT.HooS.Y.S.HansenP.S.McCormackC.ShawE.FethneyJ.ToflerG.H.Triggering of" exact="acute" post="myocardial infarction by respiratory infectionIntern. Med. J.20174752252910.1111/imj.1337728105763 51.PeirisJ.S.M.ChuC.M.ChengV.C.C.ChanK.S.HungI.F.N.PoonL.L.M.LawK.I.TangB.S.F.HonT.Y.W.ChanC.S.et al.Clinical"/>
  <result pre="myocardial infarction. The CARDIO-ARSIF registryInt. J. Cardiol.2015183172310.1016/j.ijcard.2015.01.07825662048 50.RuaneL.BuckleyT.HooS.Y.S.HansenP.S.McCormackC.ShawE.FethneyJ.ToflerG.H.Triggering of acute" exact="myocardial infarction" post="by respiratory infectionIntern. Med. J.20174752252910.1111/imj.1337728105763 51.PeirisJ.S.M.ChuC.M.ChengV.C.C.ChanK.S.HungI.F.N.PoonL.L.M.LawK.I.TangB.S.F.HonT.Y.W.ChanC.S.et al.Clinical progression and"/>
  <result pre="CARDIO-ARSIF registryInt. J. Cardiol.2015183172310.1016/j.ijcard.2015.01.07825662048 50.RuaneL.BuckleyT.HooS.Y.S.HansenP.S.McCormackC.ShawE.FethneyJ.ToflerG.H.Triggering of acute myocardial infarction by" exact="respiratory" post="infectionIntern. Med. J.20174752252910.1111/imj.1337728105763 51.PeirisJ.S.M.ChuC.M.ChengV.C.C.ChanK.S.HungI.F.N.PoonL.L.M.LawK.I.TangB.S.F.HonT.Y.W.ChanC.S.et al.Clinical progression and viral load"/>
  <result pre="infarction by respiratory infectionIntern. Med. J.20174752252910.1111/imj.1337728105763 51.PeirisJ.S.M.ChuC.M.ChengV.C.C.ChanK.S.HungI.F.N.PoonL.L.M.LawK.I.TangB.S.F.HonT.Y.W.ChanC.S.et al.Clinical progression and" exact="viral" post="load in a community outbreak of coronavirus-associated SARS pneumonia:"/>
  <result pre="pneumonia: A prospective studyLancet200310.1016/S0140-6736(03)13412-5 52.ChongP.Y.ChuiP.LingA.E.FranksT.J.TaiD.Y.H.LeoY.S.KawG.J.L.WansaicheongG.ChanK.P.OonL.L.E.et al.Analysis of deaths during the" exact="Severe" post="Acute Respiratory Syndrome (SARS) epidemic in Singapore: Challenges in"/>
  <result pre="A prospective studyLancet200310.1016/S0140-6736(03)13412-5 52.ChongP.Y.ChuiP.LingA.E.FranksT.J.TaiD.Y.H.LeoY.S.KawG.J.L.WansaicheongG.ChanK.P.OonL.L.E.et al.Analysis of deaths during the Severe" exact="Acute" post="Respiratory Syndrome (SARS) epidemic in Singapore: Challenges in determining"/>
  <result pre="prospective studyLancet200310.1016/S0140-6736(03)13412-5 52.ChongP.Y.ChuiP.LingA.E.FranksT.J.TaiD.Y.H.LeoY.S.KawG.J.L.WansaicheongG.ChanK.P.OonL.L.E.et al.Analysis of deaths during the Severe Acute" exact="Respiratory" post="Syndrome (SARS) epidemic in Singapore: Challenges in determining a"/>
  <result pre="studyLancet200310.1016/S0140-6736(03)13412-5 52.ChongP.Y.ChuiP.LingA.E.FranksT.J.TaiD.Y.H.LeoY.S.KawG.J.L.WansaicheongG.ChanK.P.OonL.L.E.et al.Analysis of deaths during the Severe Acute Respiratory" exact="Syndrome" post="(SARS) epidemic in Singapore: Challenges in determining a SARS"/>
  <result pre="Challenges in determining a SARS diagnosisArch. Pathol. Lab. Med.200412819520414736283 53.BarnesM.HeywoodA.E.MahimboA.RahmanB.NewallA.T.MaCintyreC.R.Acute" exact="myocardial infarction" post="and influenza: A meta-analysis of case-control studiesHeart201510.1136/heartjnl-2015-30769126310262 54.collab: WHOSummary"/>
  <result pre="16 April 2020) 56.BadawiA.RyooS.G.Prevalence of comorbidities in the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J."/>
  <result pre="April 2020) 56.BadawiA.RyooS.G.Prevalence of comorbidities in the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
  <result pre="Infect. Dis.20164912913310.1016/j.ijid.2016.06.01527352628 57.MatsuyamaR.NishiuraH.KutsunaS.HayakawaK.OhmagariN.Clinical determinants of the severity of Middle East" exact="respiratory" post="syndrome (MERS): A systematic review and meta-analysisBMC Public Health20161610.1186/s12889-016-3881-4"/>
  <result pre="Dis.20164912913310.1016/j.ijid.2016.06.01527352628 57.MatsuyamaR.NishiuraH.KutsunaS.HayakawaK.OhmagariN.Clinical determinants of the severity of Middle East respiratory" exact="syndrome" post="(MERS): A systematic review and meta-analysisBMC Public Health20161610.1186/s12889-016-3881-4 58.ParkJ.E.JungS.KimA.MERS"/>
  <result pre="systematic reviewBMC Public Health201810.1186/s12889-018-5484-8 59.MadjidM.Safavi-NaeiniP.SolomonS.D.VardenyO.Potential effects of coronaviruses on the" exact="cardiovascular" post="system: A reviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 60.AlhogbaniT.Acute myocarditis associated with novel"/>
  <result pre="of coronaviruses on the cardiovascular system: A reviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 60.AlhogbaniT.Acute" exact="myocarditis" post="associated with novel middle east respiratory syndrome coronavirusAnn. Saudi"/>
  <result pre="A reviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 60.AlhogbaniT.Acute myocarditis associated with novel middle east" exact="respiratory" post="syndrome coronavirusAnn. Saudi Med.201610.5144/0256-4947.2016.78 61.GuanX.YangW.SunX.WangL.MaB.LiH.ZhouJ.Association of influenza virus infection"/>
  <result pre="reviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 60.AlhogbaniT.Acute myocarditis associated with novel middle east respiratory" exact="syndrome" post="coronavirusAnn. Saudi Med.201610.5144/0256-4947.2016.78 61.GuanX.YangW.SunX.WangL.MaB.LiH.ZhouJ.Association of influenza virus infection and"/>
  <result pre="middle east respiratory syndrome coronavirusAnn. Saudi Med.201610.5144/0256-4947.2016.78 61.GuanX.YangW.SunX.WangL.MaB.LiH.ZhouJ.Association of influenza" exact="virus infection" post="and inflammatory cytokines with acute myocardial infarctionInflamm. Res.20126159159810.1007/s00011-012-0449-322373653 62.UdellJ.A.ZawiR.BhattD.L.Keshtkar-JahromiM.GaughranF.PhrommintikulA.CiszewskiA.VakiliH.HoffmanE.B.FarkouhM.E.et"/>
  <result pre="east respiratory syndrome coronavirusAnn. Saudi Med.201610.5144/0256-4947.2016.78 61.GuanX.YangW.SunX.WangL.MaB.LiH.ZhouJ.Association of influenza virus" exact="infection" post="and inflammatory cytokines with acute myocardial infarctionInflamm. Res.20126159159810.1007/s00011-012-0449-322373653 62.UdellJ.A.ZawiR.BhattD.L.Keshtkar-JahromiM.GaughranF.PhrommintikulA.CiszewskiA.VakiliH.HoffmanE.B.FarkouhM.E.et"/>
  <result pre="Med.201610.5144/0256-4947.2016.78 61.GuanX.YangW.SunX.WangL.MaB.LiH.ZhouJ.Association of influenza virus infection and inflammatory cytokines with" exact="acute" post="myocardial infarctionInflamm. Res.20126159159810.1007/s00011-012-0449-322373653 62.UdellJ.A.ZawiR.BhattD.L.Keshtkar-JahromiM.GaughranF.PhrommintikulA.CiszewskiA.VakiliH.HoffmanE.B.FarkouhM.E.et al.Association between influenza vaccination and"/>
  <result pre="acute myocardial infarctionInflamm. Res.20126159159810.1007/s00011-012-0449-322373653 62.UdellJ.A.ZawiR.BhattD.L.Keshtkar-JahromiM.GaughranF.PhrommintikulA.CiszewskiA.VakiliH.HoffmanE.B.FarkouhM.E.et al.Association between influenza vaccination and" exact="cardiovascular" post="outcomes in high-risk patients: A meta-analysisJAMA J. Am. Med."/>
  <result pre="64.HebsurS.VakilE.OetgenW.J.KumarP.N.LazarousD.F.Influenza and coronary artery disease: Exploring a clinical association with" exact="myocardial infarction" post="and analyzing the utility of vaccination in prevention of"/>
  <result pre="65.KnuutiJ.WijnsW.AchenbachS.AgewallS.BarbatoE.BaxJ.J.CapodannoD.CuissetT.DeatonC.DicksteinK.et al.2019 ESC guidelines for the diagnosis and management of" exact="chronic" post="coronary syndromesEur. Heart J.20204140747710.1093/eurheartj/ehz42531504439 66.ZhouF.YuT.DuR.FanG.LiuY.LiuZ.XiangJ.WangY.SongB.GuX.et al.Clinical course and risk"/>
  <result pre="guidelines for the diagnosis and management of chronic coronary syndromesEur." exact="Heart" post="J.20204140747710.1093/eurheartj/ehz42531504439 66.ZhouF.YuT.DuR.FanG.LiuY.LiuZ.XiangJ.WangY.SongB.GuX.et al.Clinical course and risk factors for mortality"/>
  <result pre="J.20204140747710.1093/eurheartj/ehz42531504439 66.ZhouF.YuT.DuR.FanG.LiuY.LiuZ.XiangJ.WangY.SongB.GuX.et al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: A retrospective cohort"/>
  <result pre="in Wuhan, China: A retrospective cohort studyLancet20203951054106210.1016/S0140-6736(20)30566-332171076 67.ZhengY.Y.MaY.T.ZhangJ.Y.XieX.COVID-19 and the" exact="cardiovascular" post="systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 68.LippiG.LavieC.J.Sanchis-GomarF.Cardiac troponin I in patients with"/>
  <result pre="systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 68.LippiG.LavieC.J.Sanchis-GomarF.Cardiac troponin I in patients with coronavirus" exact="disease" post="2019 (COVID-19): Evidence from a meta-analysisProg. Cardiovasc. Dis.202010.1016/j.pcad.2020.03.00132169400 69.ClerkinK.J.FriedJ.A.RaikhelkarJ.SayerG.GriffinJ.M.MasoumiA.JainS.S.BurkhoffD.KumaraiahD.RabbaniL.R.et"/>
  <result pre="2019 (COVID-19): Evidence from a meta-analysisProg. Cardiovasc. Dis.202010.1016/j.pcad.2020.03.00132169400 69.ClerkinK.J.FriedJ.A.RaikhelkarJ.SayerG.GriffinJ.M.MasoumiA.JainS.S.BurkhoffD.KumaraiahD.RabbaniL.R.et al.Coronavirus" exact="disease" post="2019 (COVID-19) and cardiovascular diseaseCirculation202010.1161/CIRCULATIONAHA.120.046941 70.IbanezB.JamesS.AgewallS.AntunesM.J.Bucciarelli-DucciC.BuenoH.CaforioA.L.P.CreaF.GoudevenosJ.A.HalvorsenS.et al.2017 ESC Guidelines"/>
  <result pre="a meta-analysisProg. Cardiovasc. Dis.202010.1016/j.pcad.2020.03.00132169400 69.ClerkinK.J.FriedJ.A.RaikhelkarJ.SayerG.GriffinJ.M.MasoumiA.JainS.S.BurkhoffD.KumaraiahD.RabbaniL.R.et al.Coronavirus disease 2019 (COVID-19) and" exact="cardiovascular" post="diseaseCirculation202010.1161/CIRCULATIONAHA.120.046941 70.IbanezB.JamesS.AgewallS.AntunesM.J.Bucciarelli-DucciC.BuenoH.CaforioA.L.P.CreaF.GoudevenosJ.A.HalvorsenS.et al.2017 ESC Guidelines for the management of"/>
  <result pre="cardiovascular diseaseCirculation202010.1161/CIRCULATIONAHA.120.046941 70.IbanezB.JamesS.AgewallS.AntunesM.J.Bucciarelli-DucciC.BuenoH.CaforioA.L.P.CreaF.GoudevenosJ.A.HalvorsenS.et al.2017 ESC Guidelines for the management of" exact="acute" post="myocardial infarction in patients presenting with ST-segment elevationEur. Heart"/>
  <result pre="diseaseCirculation202010.1161/CIRCULATIONAHA.120.046941 70.IbanezB.JamesS.AgewallS.AntunesM.J.Bucciarelli-DucciC.BuenoH.CaforioA.L.P.CreaF.GoudevenosJ.A.HalvorsenS.et al.2017 ESC Guidelines for the management of acute" exact="myocardial infarction" post="in patients presenting with ST-segment elevationEur. Heart J.20183911917710.1093/eurheartj/ehx39328886621 71.ScholzK.H.MaierS.K.G.MaierL.S.LengenfelderB.JacobshagenC.JungJ.FleischmannC.WernerG.S.OlbrichH.G.OttR.et"/>
  <result pre="of acute myocardial infarction in patients presenting with ST-segment elevationEur." exact="Heart" post="J.20183911917710.1093/eurheartj/ehx39328886621 71.ScholzK.H.MaierS.K.G.MaierL.S.LengenfelderB.JacobshagenC.JungJ.FleischmannC.WernerG.S.OlbrichH.G.OttR.et al.Impact of treatment delay on mortality in"/>
  <result pre="71.ScholzK.H.MaierS.K.G.MaierL.S.LengenfelderB.JacobshagenC.JungJ.FleischmannC.WernerG.S.OlbrichH.G.OttR.et al.Impact of treatment delay on mortality in ST-segment elevation" exact="myocardial infarction" post="(STEMI) patients presenting with and without haemodynamic instability: Results"/>
  <result pre="haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trialEur." exact="Heart" post="J.201810.1093/eurheartj/ehy00429452351 72.Two Important Messages on COVID-19 and CVDâ€&quot;YouTubeAvailable online:"/>
  <result pre="https://www.youtube.com/watch?v=ctNq26xAEx4&amp;amp;feature=emb_title(accessed on 16 April 2020) 73.GarciaS.AlbaghdadiM.S.MerajP.M.SchmidtC.GarberichR.JafferF.A.DixonS.RadeJ.J.TannenbaumM.ChambersJ.et al.Reduction in ST-Segment Elevation" exact="Cardiac" post="Catheterization Laboratory Activations in the United States during COVID-19"/>
  <result pre="en EspaÃ±aREC Interv. Cardiol.202010.24875/RECIC.M20000120 75.De RosaS.SpaccarotellaC.BassoC.CalabrÃ²M.P.CurcioA.FilardiP.P.ManconeM.MercuroG.MuscoliS.NodariS.et al.Reduction of hospitalizations for" exact="myocardial infarction" post="in Italy in the COVID-19 eraEur. Heart J.202010.1093/eurheartj/ehaa409 76.De"/>
  <result pre="hospitalizations for myocardial infarction in Italy in the COVID-19 eraEur." exact="Heart" post="J.202010.1093/eurheartj/ehaa409 76.De FilippoO.Dâ€™AscenzoF.AngeliniF.BocchinoP.P.ConrottoF.SagliettoA.SeccoG.G.CampoG.GalloneG.VerardiR.et al.Reduced rate of hospital admissions for"/>
  <result pre="in northern ItalyN. Engl. J. Med.202010.1056/NEJMc200916632343497 77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact of coronavirus" exact="disease" post="2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in"/>
  <result pre="77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation" exact="myocardial infarction" post="care in Hong Kong, ChinaCirc. Cardiovasc. Qual. Outcomes202010.1161/CIRCOUTCOMES.120.00663132182131 78.StefaniniG.G.AzzoliniE.CondorelliG.Critical"/>
  <result pre="experience from Milan, ItalyCirculation202010.1161/CIRCULATIONAHA.120.04707032207994 79.BagaiA.JollisJ.G.DauermanH.L.Andrew PengS.RokosI.C.BatesE.R.FrenchW.J.GrangerC.B.RoeM.T.Emergency department bypass for ST-segment-elevation" exact="myocardial infarction" post="patients identified with a prehospital electrocardiogram: A report from"/>
  <result pre="patients identified with a prehospital electrocardiogram: A report from the" exact="American" post="heart association mission: Lifeline programCirculation201312835235910.1161/CIRCULATIONAHA.113.00233923788525 80.WeaverW.D.SimesR.J.BetriuA.GrinesC.L.ZijlstraF.GarciaE.GrinfeldL.GibbonsR.J.RibeiroE.E.DeWoodM.A.et al.Comparison of primary"/>
  <result pre="identified with a prehospital electrocardiogram: A report from the American" exact="heart" post="association mission: Lifeline programCirculation201312835235910.1161/CIRCULATIONAHA.113.00233923788525 80.WeaverW.D.SimesR.J.BetriuA.GrinesC.L.ZijlstraF.GarciaE.GrinfeldL.GibbonsR.J.RibeiroE.E.DeWoodM.A.et al.Comparison of primary coronary"/>
  <result pre="the American heart association mission: Lifeline programCirculation201312835235910.1161/CIRCULATIONAHA.113.00233923788525 80.WeaverW.D.SimesR.J.BetriuA.GrinesC.L.ZijlstraF.GarciaE.GrinfeldL.GibbonsR.J.RibeiroE.E.DeWoodM.A.et al.Comparison of" exact="primary" post="coronary angioplasty and intravenous thrombolytic therapy for acute myocardial"/>
  <result pre="al.Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for" exact="acute" post="myocardial infarction: A quantitative reviewJ. Am. Med. Assoc.19972782093209810.1001/jama.1997.03550230069040 81.BoersmaE.Does"/>
  <result pre="time matter? A pooled analysis of randomized clinical trials comparing" exact="primary" post="percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial"/>
  <result pre="trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in" exact="acute" post="myocardial infarction patientsEur. Heart J.200610.1093/eurheartj/ehi810 82.JingZ.C.ZhuH.D.YanX.W.ChaiW.Z.ZhangS.Recommendations from the peking"/>
  <result pre="comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute" exact="myocardial infarction" post="patientsEur. Heart J.200610.1093/eurheartj/ehi810 82.JingZ.C.ZhuH.D.YanX.W.ChaiW.Z.ZhangS.Recommendations from the peking union medical"/>
  <result pre="coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patientsEur." exact="Heart" post="J.200610.1093/eurheartj/ehi810 82.JingZ.C.ZhuH.D.YanX.W.ChaiW.Z.ZhangS.Recommendations from the peking union medical college hospital"/>
  <result pre="the peking union medical college hospital for the management of" exact="acute" post="myocardial infarction during the COVID-19 outbreakEur. Heart J.20201510.1093/eurheartj/ehaa258 83.ZengJ.HuangJ.PanL.How"/>
  <result pre="peking union medical college hospital for the management of acute" exact="myocardial infarction" post="during the COVID-19 outbreakEur. Heart J.20201510.1093/eurheartj/ehaa258 83.ZengJ.HuangJ.PanL.How to balance"/>
  <result pre="the management of acute myocardial infarction during the COVID-19 outbreakEur." exact="Heart" post="J.20201510.1093/eurheartj/ehaa258 83.ZengJ.HuangJ.PanL.How to balance acute myocardial infarction and COVID-19:"/>
  <result pre="infarction during the COVID-19 outbreakEur. Heart J.20201510.1093/eurheartj/ehaa258 83.ZengJ.HuangJ.PanL.How to balance" exact="acute" post="myocardial infarction and COVID-19: The protocols from Sichuan Provincial"/>
  <result pre="during the COVID-19 outbreakEur. Heart J.20201510.1093/eurheartj/ehaa258 83.ZengJ.HuangJ.PanL.How to balance acute" exact="myocardial infarction" post="and COVID-19: The protocols from Sichuan Provincial Peopleâ€™s HospitalIntensive"/>
  <result pre="of STEMI in the COVID-19 Eraâ€&quot;Business as usual?Circulation202010.1161/CIRCULATIONAHA.120.047122 85.StefaniniG.G.MontorfanoM.TrabattoniD.AndreiniD.FerranteG.AnconaM.MetraM.CurelloS.MaffeoD.PeroG.et al.ST-elevation" exact="myocardial infarction" post="in patients with COVID-19: Clinical and angiographic outcomesCirculation202010.1161/CIRCULATIONAHA.120.04752532352306 86.HuH.MaF.WeiX.FangY.Coronavirus"/>
  <result pre="in patients with COVID-19: Clinical and angiographic outcomesCirculation202010.1161/CIRCULATIONAHA.120.04752532352306 86.HuH.MaF.WeiX.FangY.Coronavirus fulminant" exact="myocarditis" post="treated with glucocorticoid and human immunoglobulinEur. Heart J.202010.1093/eurheartj/ehaa190 87.InciardiR.M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.CaniD.S.CeriniM.FarinaD.GavazziE.et"/>
  <result pre="outcomesCirculation202010.1161/CIRCULATIONAHA.120.04752532352306 86.HuH.MaF.WeiX.FangY.Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulinEur." exact="Heart" post="J.202010.1093/eurheartj/ehaa190 87.InciardiR.M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.CaniD.S.CeriniM.FarinaD.GavazziE.et al.Cardiac involvement in a patient with coronavirus"/>
  <result pre="Heart J.202010.1093/eurheartj/ehaa190 87.InciardiR.M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.CaniD.S.CeriniM.FarinaD.GavazziE.et al.Cardiac involvement in a patient with coronavirus" exact="disease" post="2019 (COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.109632219357 88.BangaloreS.SharmaA.SlotwinerA.YatskarL.HarariR.ShahB.IbrahimH.FriedmanG.H.ThompsonC.AlviarC.L.et al.ST-segment elevation in patients with"/>
  <result pre="with covid-19â€&quot;A case seriesN. Engl. J. Med.202010.1056/NEJMc200902032302081 89.MahmudE.DauermanH.L.WeltF.G.MessengerJ.C.RaoS.V.GrinesC.MattuA.KirtaneA.J.JauharR.MerajP.et al.Management of" exact="acute" post="myocardial infarction during the COVID-19 pandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.04.03932330544"/>
  <result pre="covid-19â€&quot;A case seriesN. Engl. J. Med.202010.1056/NEJMc200902032302081 89.MahmudE.DauermanH.L.WeltF.G.MessengerJ.C.RaoS.V.GrinesC.MattuA.KirtaneA.J.JauharR.MerajP.et al.Management of acute" exact="myocardial infarction" post="during the COVID-19 pandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.04.03932330544 90.JacobsA.K.Temporary emergency"/>
  <result pre="patients with ST-elevation myocardial infarctionâ€&quot;Executive summary: A report of the" exact="American" post="College of cardiology/American heart association task force on practice"/>
  <result pre="infarctionâ€&quot;Executive summary: A report of the American College of cardiology/American" exact="heart" post="association task force on practice guidelines writing committee to"/>
  <result pre="Cardiol.200420977102510.1016/j.jacc.2004.07.00215332148 92.SCAI and CAIC Announce the Formation of the North" exact="American" post="COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI)Available online: https://www.invasivecardiology.com/news/scai-and-caic-announce-formation-north-american-covid-19-st-segment-elevation-myocardial-infarction-registry-nacmi(accessed"/>
  <result pre="the Formation of the North American COVID-19 ST-Segment Elevation Myocardial" exact="Infarction" post="Registry (NACMI)Available online: https://www.invasivecardiology.com/news/scai-and-caic-announce-formation-north-american-covid-19-st-segment-elevation-myocardial-infarction-registry-nacmi(accessed on 16 April 2020) 93.WeltF.G.P.ShahP.B.AronowH.D.BortnickA.E.HenryT.D.SherwoodM.W.YoungM.N.DavidsonL.J.KadavathS.MahmudE.et"/>
  <result pre="98.KimU.J.WonE.J.KeeS.J.JungS.I.JangH.C.Combination therapy with lopinavir/ritonavir, ribavirin and interferon-a for Middle East" exact="respiratory" post="syndromeAntivir. Ther.20162145545910.3851/IMP300226492219 99.CaoB.WangY.WenD.LiuW.WangJ.FanG.RuanL.SongB.CaiY.WeiM.et al.A trial of lopinavir-ritonavir in adults"/>
  <result pre="patients, health care workers, and health systems during the coronavirus" exact="disease" post="2019 (COVID-19) pandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.03.031 102.LittleP.Non-steroidal anti-inflammatory drugs"/>
  <result pre="bioavailability of oral metoprololBr. J. Clin. Pharmacol.200010.1046/j.1365-2125.2000.00197.x 105.CapelR.A.HerringN.KallaM.YavariA.MiramsG.R.DouglasG.BubG.ChannonK.PatersonD.J.TerrarD.A.et al.Hydroxychloroquine reduces" exact="heart" post="rate by modulating the hyperpolarization-activated current If: Novel electrophysiological"/>
  <result pre="Rhythm201510.1016/j.hrthm.2015.05.027 106.FranzosiM.G.Indications for ACE inhibitors in the early treatment of" exact="acute" post="myocardial infarction: Systematic overview of individual data from 100,000"/>
  <result pre="patients with covid-19N. Engl. J. Med.20203821653165910.1056/NEJMsr200576032227760 108.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for coronavirus" exact="disease" post="2019 (COVID-19): A reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased warfarin requirements in"/>
  <result pre="A reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased warfarin requirements in a patient with" exact="chronic hepatitis C" post="infection receiving sofosbuvir and ribavirinAm. J. Health Pharm.20177488889210.2146/ajhp16073028596225 110.PuglisiG.M.SmithS.M.JankovichR.D.AshbyC.R.JodlowskiT.Z.Paritaprevir/ritonavir/ombitasvir+dasabuvir"/>
  <result pre="reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased warfarin requirements in a patient with chronic" exact="hepatitis C" post="infection receiving sofosbuvir and ribavirinAm. J. Health Pharm.20177488889210.2146/ajhp16073028596225 110.PuglisiG.M.SmithS.M.JankovichR.D.AshbyC.R.JodlowskiT.Z.Paritaprevir/ritonavir/ombitasvir+dasabuvir"/>
  <result pre="ErmenA.Increased warfarin requirements in a patient with chronic hepatitis C" exact="infection" post="receiving sofosbuvir and ribavirinAm. J. Health Pharm.20177488889210.2146/ajhp16073028596225 110.PuglisiG.M.SmithS.M.JankovichR.D.AshbyC.R.JodlowskiT.Z.Paritaprevir/ritonavir/ombitasvir+dasabuvir plus"/>
  <result pre="111.TangN.BaiH.ChenX.GongJ.LiD.SunZ.Anticoagulant treatment is associated with decreased mortality in severe coronavirus" exact="disease" post="2019 patients with coagulopathyJ. Thromb. Haemost.202010.1111/jth.1481732220112 112.ValgimigliM.BuenoH.ByrneR.A.ColletJ.P.CostaF.JeppssonA.JÃ¼niP.KastratiA.KolhP.MauriL.et al.2017 ESC"/>
  <result pre="112.ValgimigliM.BuenoH.ByrneR.A.ColletJ.P.CostaF.JeppssonA.JÃ¼niP.KastratiA.KolhP.MauriL.et al.2017 ESC focused update on dual antiplatelet therapy in" exact="coronary artery disease" post="developed in collaboration with EACTSEur. J. Cardio-Thorac. Surg.201853347810.1093/ejcts/ezx33429045581 Figure"/>
  <result pre="al.2017 ESC focused update on dual antiplatelet therapy in coronary" exact="artery disease" post="developed in collaboration with EACTSEur. J. Cardio-Thorac. Surg.201853347810.1093/ejcts/ezx33429045581 Figure"/>
  <result pre="ESC focused update on dual antiplatelet therapy in coronary artery" exact="disease" post="developed in collaboration with EACTSEur. J. Cardio-Thorac. Surg.201853347810.1093/ejcts/ezx33429045581 Figure"/>
  <result pre="Cardio-Thorac. Surg.201853347810.1093/ejcts/ezx33429045581 Figure 1 â€œCovid-19 related delaysâ€� in treating ST-elevation" exact="myocardial infarction" post="(STEMI) patients. Adapted from Ibanez et al., 2017 European"/>
  <result pre="2017 European Society of Cardiology Guidelines for the management of" exact="acute" post="myocardial infarction in patients presenting with ST-segment elevation [70]."/>
  <result pre="European Society of Cardiology Guidelines for the management of acute" exact="myocardial infarction" post="in patients presenting with ST-segment elevation [70]. Abbreviations: Covid-19:"/>
  <result pre="FMC: first medical contact; PCI: percutaneous coronary intervention; STEMI: ST-elevation" exact="myocardial infarction." post="jcm-09-01683-t001_Table 1Table 1 Mechanisms of myocardial injury. Adapted from"/>
  <result pre="injury. Adapted from Thygesen et al. Fourth universal definition of" exact="myocardial infarction" post="(2018) [13]. Myocardial Injury Related to Primary Acute Myocardial"/>
  <result pre="definition of myocardial infarction (2018) [13]. Myocardial Injury Related to" exact="Primary" post="Acute Myocardial Ischemia Related to Oxygen Supply/Demand Imbalance Other"/>
  <result pre="of myocardial infarction (2018) [13]. Myocardial Injury Related to Primary" exact="Acute" post="Myocardial Ischemia Related to Oxygen Supply/Demand Imbalance Other Causes"/>
  <result pre="Other Causes Plaque ruptureâ€&quot;erosion with occlusive thrombosisPlaque ruptureâ€&quot;erosion with non-occlusive" exact="thrombosis" post="Reduced myocardial perfusion Cardiac conditions Coronary artery spasmMicrovascular dysfunctionCoronary"/>
  <result pre="Causes Plaque ruptureâ€&quot;erosion with occlusive thrombosisPlaque ruptureâ€&quot;erosion with non-occlusive thrombosis" exact="Reduced" post="myocardial perfusion Cardiac conditions Coronary artery spasmMicrovascular dysfunctionCoronary embolismCoronary"/>
  <result pre="with occlusive thrombosisPlaque ruptureâ€&quot;erosion with non-occlusive thrombosis Reduced myocardial perfusion" exact="Cardiac" post="conditions Coronary artery spasmMicrovascular dysfunctionCoronary embolismCoronary artery dissectionSustained bradyarrhythmiaHypotension"/>
  <result pre="dysfunctionCoronary embolismCoronary artery dissectionSustained bradyarrhythmiaHypotension or shockRespiratory failure with hypoxaemiaSevere" exact="anaemia" post="Heart failureMyocarditisCardiomyopathy (any type)Takotsubo syndromeCoronary revascularization procedureCardiac procedure other"/>
  <result pre="embolismCoronary artery dissectionSustained bradyarrhythmiaHypotension or shockRespiratory failure with hypoxaemiaSevere anaemia" exact="Heart" post="failureMyocarditisCardiomyopathy (any type)Takotsubo syndromeCoronary revascularization procedureCardiac procedure other than"/>
  <result pre="syndromeCoronary revascularization procedureCardiac procedure other than revascularizationCatheter ablationDefibrillator shocksCardiac contusion" exact="Increased" post="myocardial oxygen demand Systemic conditions Sustained tachyarrhythmiaSevere hypertension with"/>
  <result pre="other than revascularizationCatheter ablationDefibrillator shocksCardiac contusion Increased myocardial oxygen demand" exact="Systemic" post="conditions Sustained tachyarrhythmiaSevere hypertension with or without left ventricular"/>
  <result pre="shocksCardiac contusion Increased myocardial oxygen demand Systemic conditions Sustained tachyarrhythmiaSevere" exact="hypertension" post="with or without left ventricular hypertrophy Sepsis, infectious diseaseChronic"/>
  <result pre="Systemic conditions Sustained tachyarrhythmiaSevere hypertension with or without left ventricular" exact="hypertrophy" post="Sepsis, infectious diseaseChronic kidney diseaseStroke, subarachnoid hemorrhagePulmonary embolism, pulmonary"/>
  <result pre="Sustained tachyarrhythmiaSevere hypertension with or without left ventricular hypertrophy Sepsis," exact="infectious" post="diseaseChronic kidney diseaseStroke, subarachnoid hemorrhagePulmonary embolism, pulmonary hypertensionInfiltrative diseases,"/>
  <result pre="ventricular hypertrophy Sepsis, infectious diseaseChronic kidney diseaseStroke, subarachnoid hemorrhagePulmonary embolism," exact="pulmonary" post="hypertensionInfiltrative diseases, e.g., amyloidosis, sarcoidosisChemotherapeutic agentsCritically ill patientsStrenuous exercise"/>
  <result pre="e.g., amyloidosis, sarcoidosisChemotherapeutic agentsCritically ill patientsStrenuous exercise jcm-09-01683-t002_Table 2Table 2" exact="Acute" post="coronary syndromes and other acute respiratory infectionâ€&quot;main studies. Study,"/>
  <result pre="patientsStrenuous exercise jcm-09-01683-t002_Table 2Table 2 Acute coronary syndromes and other" exact="acute" post="respiratory infectionâ€&quot;main studies. Study, Year, Journal Infection Population and"/>
  <result pre="exercise jcm-09-01683-t002_Table 2Table 2 Acute coronary syndromes and other acute" exact="respiratory" post="infectionâ€&quot;main studies. Study, Year, Journal Infection Population and Timeline"/>
  <result pre="syndromes and other acute respiratory infectionâ€&quot;main studies. Study, Year, Journal" exact="Infection" post="Population and Timeline Myocardial Infarction Diagnosis Cases with Myocardial"/>
  <result pre="infectionâ€&quot;main studies. Study, Year, Journal Infection Population and Timeline Myocardial" exact="Infarction" post="Diagnosis Cases with Myocardial Infarction and Respiratory Infectious Disease"/>
  <result pre="Infection Population and Timeline Myocardial Infarction Diagnosis Cases with Myocardial" exact="Infarction" post="and Respiratory Infectious Disease Smeeth et al., 2004, New"/>
  <result pre="and Timeline Myocardial Infarction Diagnosis Cases with Myocardial Infarction and" exact="Respiratory" post="Infectious Disease Smeeth et al., 2004, New England Journal"/>
  <result pre="Timeline Myocardial Infarction Diagnosis Cases with Myocardial Infarction and Respiratory" exact="Infectious" post="Disease Smeeth et al., 2004, New England Journal of"/>
  <result pre="Myocardial Infarction Diagnosis Cases with Myocardial Infarction and Respiratory Infectious" exact="Disease" post="Smeeth et al., 2004, New England Journal of Medicine"/>
  <result pre="Smeeth et al., 2004, New England Journal of Medicine [42]" exact="Systemic" post="respiratory tract infection (pneumonia, acute bronchitis, chest infections, and"/>
  <result pre="et al., 2004, New England Journal of Medicine [42] Systemic" exact="respiratory" post="tract infection (pneumonia, acute bronchitis, chest infections, and influenza)"/>
  <result pre="2004, New England Journal of Medicine [42] Systemic respiratory tract" exact="infection" post="(pneumonia, acute bronchitis, chest infections, and influenza) MI diagnosed"/>
  <result pre="England Journal of Medicine [42] Systemic respiratory tract infection (pneumonia," exact="acute" post="bronchitis, chest infections, and influenza) MI diagnosed 91 days"/>
  <result pre="of Medicine [42] Systemic respiratory tract infection (pneumonia, acute bronchitis," exact="chest" post="infections, and influenza) MI diagnosed 91 days after infection"/>
  <result pre="bronchitis, chest infections, and influenza) MI diagnosed 91 days after" exact="infection" post="exposure UK GPRD data (1495 cases were excluded because"/>
  <result pre="date of the MI was uncertain) MI: n = 3254Respiratory" exact="infectious" post="disease: n = 20,921 Kwong et al., 2018, New"/>
  <result pre="confirmation of influenza ICD-10 diagnostic code MI: n = 364Respiratory" exact="infectious" post="disease: n = 19,045 Warren-Gash et al., 2013, British"/>
  <result pre="et al., 2013, British Medical Journal [44] Influenza A H1N1" exact="Respiratory" post="tract infection developed within one month before admission for"/>
  <result pre="2013, British Medical Journal [44] Influenza A H1N1 Respiratory tract" exact="infection" post="developed within one month before admission for MI cTn"/>
  <result pre="ECG changes, or by angiographic findings MI: n = 134Respiratory" exact="infectious" post="disease: n = 13 Violi et al., 2017, Clinical"/>
  <result pre="infectious disease: n = 13 Violi et al., 2017, Clinical" exact="infectious diseases" post="[45] CAP MI during hospitalization for CAP Third universal"/>
  <result pre="AMI MI: n = 89(NSTEMI = 78 STEMI = 11)Respiratory" exact="infectious" post="disease: n = 1182 Musher et al., 2007, Clinical"/>
  <result pre="infectious disease: n = 1182 Musher et al., 2007, Clinical" exact="infectious diseases" post="[46] Pneumococcal pneumonia MI diagnosed at hospital admission for"/>
  <result pre="= 1182 Musher et al., 2007, Clinical infectious diseases [46]" exact="Pneumococcal" post="pneumonia MI diagnosed at hospital admission for pneumonia New"/>
  <result pre="1182 Musher et al., 2007, Clinical infectious diseases [46] Pneumococcal" exact="pneumonia" post="MI diagnosed at hospital admission for pneumonia New ECG"/>
  <result pre="diseases [46] Pneumococcal pneumonia MI diagnosed at hospital admission for" exact="pneumonia" post="New ECG abnormalities (i.e., ST segment elevation or depression"/>
  <result pre="for pneumonia New ECG abnormalities (i.e., ST segment elevation or" exact="depression" post="or Q waves) accompanied by cTn elevation MI: n"/>
  <result pre="elevation MI: n = 12(NSTEMI = 9 STEMI = 3)Respiratory" exact="infectious" post="disease: n = 170 Corrales-Medina et al., 2015, Journal"/>
  <result pre="disease: n = 170 Corrales-Medina et al., 2015, Journal of" exact="American" post="Medical Association [47] Pneumonia MI and fatal coronary heart"/>
  <result pre="Corrales-Medina et al., 2015, Journal of American Medical Association [47]" exact="Pneumonia" post="MI and fatal coronary heart disease over 10 years"/>
  <result pre="Journal of American Medical Association [47] Pneumonia MI and fatal" exact="coronary heart disease" post="over 10 years after pneumonia hospitalization Two algorithms based"/>
  <result pre="of American Medical Association [47] Pneumonia MI and fatal coronary" exact="heart" post="disease over 10 years after pneumonia hospitalization Two algorithms"/>
  <result pre="American Medical Association [47] Pneumonia MI and fatal coronary heart" exact="disease" post="over 10 years after pneumonia hospitalization Two algorithms based"/>
  <result pre="MI and fatal coronary heart disease over 10 years after" exact="pneumonia" post="hospitalization Two algorithms based on symptoms, cardiac enzymes, and"/>
  <result pre="symptoms, cardiac enzymes, and electrocardiographic evidence MI: n = 247Respiratory" exact="infectious" post="disease: n = 1271 Vejpongsa et al., 2019, The"/>
  <result pre="infectious disease: n = 1271 Vejpongsa et al., 2019, The" exact="American" post="Journal of Medicine [48] Acute influenza and other viral"/>
  <result pre="Vejpongsa et al., 2019, The American Journal of Medicine [48]" exact="Acute" post="influenza and other viral respiratory infections Acute influenza and"/>
  <result pre="The American Journal of Medicine [48] Acute influenza and other" exact="viral" post="respiratory infections Acute influenza and other viral infections in"/>
  <result pre="American Journal of Medicine [48] Acute influenza and other viral" exact="respiratory" post="infections Acute influenza and other viral infections in hospital"/>
  <result pre="Journal of Medicine [48] Acute influenza and other viral respiratory" exact="infections" post="Acute influenza and other viral infections in hospital admission"/>
  <result pre="of Medicine [48] Acute influenza and other viral respiratory infections" exact="Acute" post="influenza and other viral infections in hospital admission for"/>
  <result pre="influenza and other viral respiratory infections Acute influenza and other" exact="viral" post="infections in hospital admission for MI ICD-9 diagnostic code"/>
  <result pre="and other viral respiratory infections Acute influenza and other viral" exact="infections" post="in hospital admission for MI ICD-9 diagnostic code MI:"/>
  <result pre="admission for MI ICD-9 diagnostic code MI: n = 1,884,985Respiratory" exact="infectious" post="disease: n = 21,370(Acute influenza = 9885 Other ="/>
  <result pre="al., 2015, International Journal of Cardiology [49] Wide spectrum of" exact="respiratory" post="tract infection (flu-like illness with fever and sore throat),"/>
  <result pre="International Journal of Cardiology [49] Wide spectrum of respiratory tract" exact="infection" post="(flu-like illness with fever and sore throat), pneumonia or"/>
  <result pre="respiratory tract infection (flu-like illness with fever and sore throat)," exact="pneumonia" post="or bronchitis Possible exposure to respiratory infection within 35"/>
  <result pre="infection (flu-like illness with fever and sore throat), pneumonia or" exact="bronchitis" post="Possible exposure to respiratory infection within 35 days prior"/>
  <result pre="fever and sore throat), pneumonia or bronchitis Possible exposure to" exact="respiratory" post="infection within 35 days prior to admission for MI"/>
  <result pre="and sore throat), pneumonia or bronchitis Possible exposure to respiratory" exact="infection" post="within 35 days prior to admission for MI Angiographically"/>
  <result pre="admission for MI Angiographically confirmed MI MI: n = 578Respiratory" exact="infectious" post="disease: n = 123 Ruane et al., 2017, Internal"/>
  <result pre="epidemic Angiographically confirmed STEMI (â‰¤24 h) with at least â‰¥50%" exact="coronary stenosis" post="MI: n = 11,987Respiratory infectious disease: n = NA"/>
  <result pre="Angiographically confirmed STEMI (â‰¤24 h) with at least â‰¥50% coronary" exact="stenosis" post="MI: n = 11,987Respiratory infectious disease: n = NA"/>
  <result pre="with at least â‰¥50% coronary stenosis MI: n = 11,987Respiratory" exact="infectious" post="disease: n = NA (ERR 8.9) Peiris et al,"/>
  <result pre="hospitalized patients with SARS Not reported MI: n = 2Respiratory" exact="infectious" post="disease: n = 75 Chong et al., 2004, Archives"/>
  <result pre="Medicine [52] SARS-CoV MI in post-mortem examinations for confirmed SARS" exact="infections" post="Post-mortem MI: n = 2Respiratory infectious disease: n ="/>
  <result pre="examinations for confirmed SARS infections Post-mortem MI: n = 2Respiratory" exact="infectious" post="disease: n = 8 No data available MERS NA"/>
  <result pre="= 8 No data available MERS NA Abbreviations: CAP: community" exact="acquired" post="pneumonia; CoV: coronavirus; cTn: cardiac troponin; GPRD: General Practice"/>
  <result pre="CAP: community acquired pneumonia; CoV: coronavirus; cTn: cardiac troponin; GPRD:" exact="General" post="Practice Research Database; ERR: excess relative risk; HMPV: human"/>
  <result pre="parainfluenza virus; ICD: international classification of diseases; MERS: Middle East" exact="respiratory" post="syndrome; MI: myocardial infarction; NA: not available, NSTEMI: myocardial"/>
  <result pre="international classification of diseases; MERS: Middle East respiratory syndrome; MI:" exact="myocardial infarction;" post="NA: not available, NSTEMI: myocardial infarction without ST-segment elevation;"/>
  <result pre="East respiratory syndrome; MI: myocardial infarction; NA: not available, NSTEMI:" exact="myocardial infarction" post="without ST-segment elevation; RSV: respiratory syncytial virus; SARS-CoV: severe"/>
  <result pre="NA: not available, NSTEMI: myocardial infarction without ST-segment elevation; RSV:" exact="respiratory" post="syncytial virus; SARS-CoV: severe acute respiratory syndrome coronavirus; STEMI:"/>
  <result pre="infarction without ST-segment elevation; RSV: respiratory syncytial virus; SARS-CoV: severe" exact="acute" post="respiratory syndrome coronavirus; STEMI: ST-segment elevation myocardial infarction; UK:"/>
  <result pre="without ST-segment elevation; RSV: respiratory syncytial virus; SARS-CoV: severe acute" exact="respiratory" post="syndrome coronavirus; STEMI: ST-segment elevation myocardial infarction; UK: United"/>
  <result pre="ST-segment elevation; RSV: respiratory syncytial virus; SARS-CoV: severe acute respiratory" exact="syndrome" post="coronavirus; STEMI: ST-segment elevation myocardial infarction; UK: United Kingdom."/>
  <result pre="virus; SARS-CoV: severe acute respiratory syndrome coronavirus; STEMI: ST-segment elevation" exact="myocardial infarction;" post="UK: United Kingdom. jcm-09-01683-t003_Table 3Table 3 Myocardial injury and"/>
  <result pre="n = 6 (15%) Wang et al., 2020, Journal of" exact="American" post="Medical Association [1] n = 138ICU = 36Non-ICU ="/>
  <result pre="n = 54 (28.3%) Shi et al., 2020, Journal of" exact="American" post="Medical Association: Cardiology [6] n = 416 Myocardial injury"/>
  <result pre="= 42 (51.2%)Without cardiac injury = 15 (4.5%) Abbreviations: ACS:" exact="acute" post="coronary syndromes; AMI: acute myocardial infarction; ECG: electrocardiogram; ICU:"/>
  <result pre="injury = 15 (4.5%) Abbreviations: ACS: acute coronary syndromes; AMI:" exact="acute" post="myocardial infarction; ECG: electrocardiogram; ICU: intensive care unit; NA:"/>
  <result pre="= 15 (4.5%) Abbreviations: ACS: acute coronary syndromes; AMI: acute" exact="myocardial infarction;" post="ECG: electrocardiogram; ICU: intensive care unit; NA: not available;"/>
  <result pre="ECG: electrocardiogram; ICU: intensive care unit; NA: not available; NSTEMI:" exact="myocardial infarction" post="without ST-segment elevation; STEMI: ST-segment elevation myocardial infarction. jcm-09-01683-t004_Table"/>
  <result pre="available; NSTEMI: myocardial infarction without ST-segment elevation; STEMI: ST-segment elevation" exact="myocardial infarction." post="jcm-09-01683-t004_Table 4Table 4 Drug treatment of acute coronary syndromes"/>
  <result pre="ST-segment elevation myocardial infarction. jcm-09-01683-t004_Table 4Table 4 Drug treatment of" exact="acute" post="coronary syndromes and coronary artery diseaseâ€&quot;evidence and potential interactions"/>
  <result pre="no contraindications [101].Contraindications to prasugrel: previous intracranial hemorrhage, previous ischemic" exact="stroke" post="or TIA, or ongoing bleeds; prasugrel is not recommended"/>
  <result pre="-Labetalol Chloroquineâ€&quot;Hydroxychloroquine Fingolimod Hydroxychloroquine has a potential role in reducing" exact="heart" post="rate and may increase effect of beta-blockers [105]. When"/>
  <result pre="[108]. Abrupt withdrawal in high-risk patients, especially those who have" exact="heart" post="failure or have had MI, may result in clinical"/>
  <result pre="First evidences showed decreased mortality in severe Covid-19 patients with" exact="coagulopathy" post="[111]. Given the interactions between some antiviral drugs and"/>
  <result pre="ACE inhibitors; ARBs: angiotensin receptor blockers; Covid-19: coronavirus disease; MI:" exact="myocardial infarction;" post="NSAIDS: nonsteroidal anti-inflammatory drugs; NSTE-ACS: acute coronary syndromes without"/>
  <result pre="coronavirus disease; MI: myocardial infarction; NSAIDS: nonsteroidal anti-inflammatory drugs; NSTE-ACS:" exact="acute" post="coronary syndromes without ST-segment elevation; OACs: oral anticoagulants; TIA:"/>
  <result pre="acute coronary syndromes without ST-segment elevation; OACs: oral anticoagulants; TIA:" exact="transient ischemic attack." post=""/>
 </snippets>
</snippetsTree>
